The Cooper Companies, Inc. (COO)
San Ramon, CA, US
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Based on only 1 article — low confidence
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Oclaro, Inc. | OCLR | 2004-08-20 | View |
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2016-09-22 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.78% | +1.96% | +0.81% | -24.35% | -19.49% | -24.33% | -8.01% | -29.83% | -35.05% | +52.12% | +687.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 6 | 0 |
| Hold | 5 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
61.00
-14.5%
|
| Last Quarter | 1 |
61.00
-14.5%
|
| Last Year | 18 |
87.17
+22.2%
|
| All Time | 30 |
146.65
+105.6%
|
-
Revenue growth Medical - Instruments & Supplies: +7.9%+5.1% Q2'26: +7.9% (vs Q2'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-4.6% Q2'26: -191.5% (vs Q2'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+2.8% ★ Q2'26: +14.7% (vs Q2'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+15.4% ★ Q2'26: +0.0% (vs Q2'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+3.8% Q2'26: +0.0% (vs Q2'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.2% ★ Q2'26: -2.8% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×2.64× Q2'26: -19.84× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Oct 1998 actual |
Oct 1999 actual |
Oct 2000 actual |
Oct 2001 actual |
Oct 2002 actual |
Oct 2003 actual |
Oct 2004 actual |
Oct 2005 actual |
Oct 2006 actual |
Oct 2007 actual |
Oct 2008 actual |
Oct 2009 actual |
Oct 2010 actual |
Oct 2011 actual |
Oct 2012 actual |
Oct 2013 actual |
Oct 2014 actual |
Oct 2015 actual |
Oct 2016 actual |
Oct 2017 actual |
Oct 2018 actual |
Oct 2019 actual |
Oct 2020 actual |
Oct 2021 actual |
Oct 2022 actual |
Oct 2023 actual |
Oct 2024 actual |
Oct 2025 actual |
Oct 2026 13 Rev. Ana. 11 EPS Ana. |
Oct 2027 13 Rev. Ana. 11 EPS Ana. |
Oct 2028 10 Rev. Ana. 7 EPS Ana. |
Oct 2029 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
147.20M
est: 110.82M (+32.8%)
|
165.30M
est: 156.77M (+5.4%)
|
197.32M
est: 193.44M (+2.0%)
|
234.57M
est: 230.35M (+1.8%)
|
315.31M
est: 298.54M (+5.6%)
|
411.79M
est: 395.64M (+4.1%)
|
490.18M
est: 459.30M (+6.7%)
|
806.62M
est: 778.08M (+3.7%)
|
858.96M
est: 1.02B (-15.5%)
|
950.64M
est: 1.14B (-16.8%)
|
1.06B
est: 1.01B (+5.7%)
|
1.08B
est: 1.03B (+5.2%)
|
1.16B
est: 1.05B (+10.7%)
|
1.33B
est: 1.16B (+15.0%)
|
1.45B
est: 1.43B (+1.3%)
|
1.59B
est: 1.63B (-2.5%)
|
1.72B
est: 1.70B (+0.9%)
|
1.80B
est: 1.82B (-1.1%)
|
1.97B
est: 1.95B (+0.7%)
|
2.14B
est: 2.14B (+0.1%)
|
2.53B
est: 2.53B (+0.3%)
|
2.65B
est: 2.65B (+0.3%)
|
2.43B
est: 2.43B (+0.2%)
|
2.92B
est: 2.91B (+0.4%)
|
3.31B
est: 3.30B (+0.3%)
|
3.59B
est: 3.73B (-3.7%)
|
3.90B
est: 3.90B (-0.2%)
|
4.09B
est: 4.09B (+0.1%)
|
4.32B
4.31B – 4.33B
+5.7% YoY
|
4.54B
4.52B – 4.58B
+5.1% YoY
|
4.78B
4.78B – 4.79B
+5.3% YoY
|
5.03B
4.98B – 5.07B
+5.2% YoY
|
| EBITDA |
38.20M
est: 10.07M (+279.4%)
|
47.25M
est: 39.94M (+18.3%)
|
55.60M
est: 47.36M (+17.4%)
|
65.75M
est: 60.98M (+7.8%)
|
78.34M
est: 72.30M (+8.4%)
|
107.77M
est: 98.97M (+8.9%)
|
132.40M
est: 120.00M (+10.3%)
|
192.93M
est: 149.81M (+28.8%)
|
180.93M
est: 153.79M (+17.6%)
|
140.04M
est: 94.74M (+47.8%)
|
209.18M
est: 149.75M (+39.7%)
|
251.57M
est: 227.93M (+10.4%)
|
255.10M
est: 215.42M (+18.4%)
|
308.26M
est: 257.37M (+19.8%)
|
398.44M
est: 390.91M (+1.9%)
|
446.79M
est: 447.99M (-0.3%)
|
442.70M
est: 433.38M (+2.2%)
|
425.00M
est: 414.18M (+2.6%)
|
520.10M
est: 489.43M (+6.3%)
|
615.80M
est: 588.83M (+4.6%)
|
689.70M
est: 681.29M (+1.2%)
|
826.20M
est: 779.31M (+6.0%)
|
590.40M
est: 556.12M (+6.2%)
|
823.90M
est: 771.69M (+6.8%)
|
878.70M
est: 903.20M (-2.7%)
|
885.90M
est: 990.03M (-10.5%)
|
1.07B
est: 1.04B (+3.5%)
|
1.05B
est: 1.08B (-2.9%)
|
1.15B
1.14B – 1.15B
+5.7% YoY
|
1.21B
1.20B – 1.22B
+5.1% YoY
|
1.27B
1.27B – 1.27B
+5.3% YoY
|
1.34B
1.32B – 1.34B
+5.2% YoY
|
| EBIT |
29.80M
est: 27.33M (+9.1%)
|
38.81M
est: 36.70M (+5.8%)
|
46.87M
est: 45.88M (+2.2%)
|
54.76M
est: 52.91M (+3.5%)
|
66.97M
est: 63.32M (+5.8%)
|
95.24M
est: 91.49M (+4.1%)
|
116.75M
est: 109.37M (+6.7%)
|
144.30M
est: 129.10M (+11.8%)
|
119.29M
est: 377.34M (-68.4%)
|
55.53M
est: 49.90M (+11.3%)
|
126.99M
est: 119.34M (+6.4%)
|
158.97M
est: 137.78M (+15.4%)
|
161.09M
est: 161.76M (-0.4%)
|
210.11M
est: 190.27M (+10.4%)
|
287.22M
est: 277.51M (+3.5%)
|
321.44M
est: 306.57M (+4.8%)
|
304.50M
est: 300.17M (+1.4%)
|
233.60M
est: 230.00M (+1.6%)
|
321.80M
est: 306.98M (+4.8%)
|
427.40M
est: 410.14M (+4.2%)
|
414.60M
est: 398.98M (+3.9%)
|
545.40M
est: 516.58M (+5.6%)
|
303.30M
est: 288.25M (+5.2%)
|
514.60M
est: 473.62M (+8.7%)
|
532.60M
est: 517.48M (+2.9%)
|
518.20M
est: 607.60M (-14.7%)
|
696.60M
est: 635.70M (+9.6%)
|
630.40M
est: 665.71M (-5.3%)
|
703.58M
701.95M – 705.21M
+5.7% YoY
|
739.57M
736.32M – 746.08M
+5.1% YoY
|
778.93M
778.57M – 779.29M
+5.3% YoY
|
819.78M
811.34M – 825.27M
+5.2% YoY
|
| Net Income |
39.80M
est: 37.32M (+6.7%)
|
25.10M
est: 23.58M (+6.4%)
|
28.97M
est: 28.38M (+2.1%)
|
37.14M
est: 35.89M (+3.5%)
|
48.88M
est: 46.24M (+5.7%)
|
68.77M
est: 66.05M (+4.1%)
|
92.83M
est: 86.79M (+6.9%)
|
91.72M
est: 86.83M (+5.6%)
|
66.23M
est: 75.30M (-12.0%)
|
-11.19M
est: -15.81M (+29.2%)
|
65.48M
est: 60.79M (+7.7%)
|
100.55M
est: 91.98M (+9.3%)
|
112.80M
est: 90.60M (+24.5%)
|
175.43M
est: 145.67M (+20.4%)
|
248.34M
est: 243.22M (+2.1%)
|
296.15M
est: 296.34M (-0.1%)
|
269.86M
est: 263.96M (+2.2%)
|
203.52M
est: 198.01M (+2.8%)
|
273.92M
est: 259.17M (+5.7%)
|
372.90M
est: 356.07M (+4.7%)
|
139.90M
est: 158.50M (-11.7%)
|
466.70M
est: 440.03M (+6.1%)
|
238.40M
est: 216.53M (+10.1%)
|
2.94B
est: 2.62B (+12.3%)
|
385.80M
est: 1.00B (-61.6%)
|
294.20M
est: 339.90M (-13.4%)
|
392.30M
est: 730.57M (-46.3%)
|
374.90M
est: 819.32M (-54.2%)
|
923.91M
915.91M – 931.91M
+12.8% YoY
|
1.00B
983.02M – 1.02B
+8.2% YoY
|
1.09B
951.40M – 1.24B
+9.5% YoY
|
1.19B
1.18B – 1.20B
+8.9% YoY
|
| SGA |
56.20M
est: 52.68M (+6.7%)
|
61.70M
est: 58.44M (+5.6%)
|
75.42M
est: 73.95M (+2.0%)
|
89.77M
est: 86.68M (+3.6%)
|
126.73M
est: 119.81M (+5.8%)
|
162.85M
est: 156.56M (+4.0%)
|
190.53M
est: 178.52M (+6.7%)
|
297.95M
est: 285.95M (+4.2%)
|
357.84M
est: 410.62M (-12.9%)
|
407.95M
est: 470.52M (-13.3%)
|
429.30M
est: 411.69M (+4.3%)
|
391.59M
est: 359.41M (+9.0%)
|
433.06M
est: 379.73M (+14.0%)
|
513.14M
est: 432.91M (+18.5%)
|
559.90M
est: 548.67M (+2.0%)
|
596.65M
est: 605.42M (-1.4%)
|
683.12M
est: 677.85M (+0.8%)
|
712.54M
est: 700.09M (+1.8%)
|
722.80M
est: 678.99M (+6.5%)
|
799.10M
est: 765.93M (+4.3%)
|
973.30M
est: 959.74M (+1.4%)
|
996.60M
est: 935.89M (+6.5%)
|
992.50M
est: 969.09M (+2.4%)
|
1.21B
est: 1.14B (+5.9%)
|
1.34B
est: 1.37B (-2.2%)
|
1.50B
est: 1.51B (-0.9%)
|
1.53B
est: 1.58B (-3.2%)
|
1.63B
est: 1.66B (-1.9%)
|
1.75B
1.75B – 1.76B
+5.7% YoY
|
1.84B
1.84B – 1.86B
+5.1% YoY
|
1.94B
1.94B – 1.94B
+5.3% YoY
|
2.04B
2.02B – 2.06B
+5.2% YoY
|
| EPS |
1.35
est: 1.00 (+35.0%)
|
0.89
est: 0.70 (+27.1%)
|
1.02
est: 0.97 (+5.2%)
|
1.25
est: 1.15 (+8.7%)
|
1.60
est: 1.42 (+12.7%)
|
2.20
est: 1.98 (+11.1%)
|
2.83
est: 2.36 (+19.9%)
|
2.06
est: 2.87 (-28.2%)
|
1.49
est: 3.29 (-54.7%)
|
-0.25
est: 2.88 (-108.7%)
|
1.46
est: 2.06 (-29.1%)
|
2.23
est: 2.04 (+9.3%)
|
2.48
est: 2.32 (+6.9%)
|
3.74
est: 3.30 (+13.3%)
|
5.18
est: 5.00 (+3.6%)
|
6.09
est: 6.23 (-2.2%)
|
5.61
est: 6.92 (-18.9%)
|
4.20
est: 1.89 (+122.6%)
|
5.65
est: 2.11 (+168.3%)
|
7.63
est: 2.43 (+214.2%)
|
2.85
est: 2.90 (-1.8%)
|
9.47
est: 3.08 (+207.4%)
|
4.86
est: 2.39 (+103.0%)
|
59.73
est: 3.33 (+1,692.4%)
|
1.96
est: 3.20 (-38.7%)
|
1.49
est: 1.71 (-13.0%)
|
1.97
est: 3.66 (-46.1%)
|
1.88
est: 4.10 (-54.1%)
|
4.62
4.58 – 4.66
+12.8% YoY
|
5.03
4.92 – 5.09
+8.8% YoY
|
5.45
4.76 – 6.19
+8.5% YoY
|
5.96
5.88 – 6.02
+9.3% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-28 | Citigroup | Neutral | Neutral | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 16.67M | 8.40% | 15.39M | — | 16.67M | — | HC | Delaware | 2024-11-08 | ↗ |
| 2 | Jay L. Schottenstein | 14.16M | 19.30% | 12.03M | 2.12M | 10.77M | 2.12M | IN | — | 2021-10-01 | ↗ |
| 3 | The Vanguard Group - 23-1945930 | 6.76M | 10.30% | — | 135.1K | 6.57M | 184.9K | IA | Pennsylvania | 2022-03-09 | ↗ |
| 4 | Investment Counselors of Maryland, LLC | 3.87M | 5.99% | 2.61M | 1.27M | 3.87M | — | IA | — | 2021-02-12 | ↗ |
| 5 | William Blair Investment Management, LLC | 3.77M | 5.80% | 2.43M | — | 3.77M | — | IA | Delaware | 2022-02-10 | ↗ |
| 6 | 52-0556948 | 3.16M | 6.30% | 1.19M | — | — | — | IA | Maryland | 2022-02-14 | ↗ |
| 7 | Mark Cohen | 3.00M | 6.30% | — | 3.00M | — | 3.00M | HC, IN | Delaware | 2024-09-17 | ↗ |
| 8 | SH Capital Partners, L.P. | 3.00M | 6.30% | — | 3.00M | — | 3.00M | PN | Delaware | 2024-09-17 | ↗ |
| 9 | Stone House Capital Management, LLC | 3.00M | 6.30% | — | 3.00M | — | 3.00M | IA, OO | Delaware | 2024-09-17 | ↗ |
| 10 | Israel A. Englander | 2.99M | 5.10% | — | 2.99M | — | 2.99M | IN | — | 2023-07-05 | ↗ |
| 11 | Millennium Group Management LLC | 2.99M | 5.10% | — | 2.99M | — | 2.99M | OO | — | 2023-07-05 | ↗ |
| 12 | Millennium Management LLC | 2.99M | 5.10% | — | 2.99M | — | 2.99M | OO | — | 2023-07-05 | ↗ |
| 13 | 30-0447847 | 2.75M | 5.80% | 2.69M | — | 2.75M | — | IA | Delaware | 2024-10-31 | ↗ |
| 14 | 85-4328500 | 2.47M | 5.00% | 984.0K | — | 2.47M | — | IA | Maryland | 2023-02-14 | ↗ |
| 15 | D. E. Shaw & Co., L.P. | 2.41M | 5.00% | — | 2.40M | — | — | IA, PN | Delaware | 2024-09-23 | ↗ |
| 16 | David E. Shaw | 2.41M | 5.00% | — | 2.40M | — | — | IN | Delaware | 2024-09-23 | ↗ |
| 17 | EIN #00-0000000 | 2.16M | 4.40% | — | 2.16M | — | 2.16M | IA, HC | Jersey Channel Islands | 2021-02-11 | ↗ |
| 18 | STATE STREET CORPORATION | 2.12M | 4.32% | — | 1.88M | — | 2.11M | HC | BOSTON, MASSACHUSETTS | 2020-02-13 | ↗ |
| 19 | 04-2747644 | 1.91M | 3.90% | 1.88M | — | 1.91M | — | IA | Delaware | 2020-02-14 | ↗ |
| 20 | Fuller & Thaler Asset Management, Inc. | 1.89M | 2.92% | 1.83M | — | 1.89M | — | IA | California | 2021-02-11 | ↗ |
| 21 | Generation Investment Management LLP | 1.53M | 3.10% | 11.2K | 1.52M | 11.2K | — | IA | and Wales | 2021-02-16 | ↗ |
| 22 | BARCLAYS GLOBAL INVESTORS, NA. | 1.47M | 3.04% | — | 2.76M | — | 2.76M | BK | Jersey Channel Islands | 2019-02-12 | ↗ |
| 23 | Generation Investment Management US LLP | 743.6K | 1.50% | — | 743.6K | — | — | IA | Delaware | 2021-02-16 | ↗ |
| 24 | Generation IM Fund plc | 449.4K | 0.90% | — | 449.4K | — | — | CO | Ireland | 2021-02-16 | ↗ |
| 25 | Generation IM Global Equity Fund LLC | 385.4K | 0.80% | — | 385.4K | — | — | OO | Delaware | 2021-02-16 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 23.55M -425.9K (-1.8%) | 1.93B +286.4M (+17.4%) | 11.89% -0.064 pp | 0.03% +0.003 pp | USD98.51 -16.8% | 8 qtrs — |
| 2 | BLACKROCK, INC. | 16.49M +1.2M (+7.6%) | 1.35B +300.7M (+28.6%) | 8.32% +0.683 pp | 0.02% +0.004 pp | USD107.96 -24.1% | 6 qtrs — |
| 3 | CAPITAL WORLD INVESTORS | 10.21M -343.4K (-3.3%) | 836.66M +113.2M (+15.7%) | 5.10% -0.156 pp | 0.11% +0.015 pp | USD86.22 -4.9% | 8 qtrs — |
| 4 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 9.05M -779.5K (-7.9%) | 741.50M +67.8M (+10.1%) | 4.57% -0.332 pp | 0.47% +0.056 pp | USD91.35 -10.3% | 8 qtrs — |
| 5 | STATE STREET CORP | 8.79M +207.2K (+2.4%) | 720.74M +132.0M (+22.4%) | 4.44% +0.159 pp | 0.02% +0.004 pp | USD98.45 -16.7% | 8 qtrs — |
| 6 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 7.20M -351.4K (-4.7%) | 590.02M +72.4M (+14.0%) | 3.63% -0.130 pp | 1.58% +0.322 pp | USD99.23 -17.4% | 8 qtrs — |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.03M +2.2M (+58.8%) | 494.12M +233.8M (+89.8%) | 3.01% +1.122 pp | 0.05% +0.025 pp | USD83.46 -1.8% | 8 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 5.27M -28.0K (-0.5%) | 430.66M +68.5M (+18.9%) | 2.66% +0.019 pp | 0.03% +0.004 pp | USD97.26 -15.7% | 8 qtrs — |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 4.18M -2.0M (-32.4%) | 342.57M -81.5M (-19.2%) | 2.11% -0.973 pp | 0.06% -0.014 pp | USD69.75 +17.5% | 8 qtrs — |
| 10 | FRANKLIN RESOURCES INC | 4.02M +2.1M (+108.2%) | 329.65M +197.2M (+148.8%) | 2.01% +1.048 pp | 0.08% +0.048 pp | USD76.66 +6.9% | 8 qtrs — |
| 11 | BROWNING WEST LP | 3.69M +3.7M (+100.0%) | 302.52M +302.5M (+100.0%) | 1.86% +1.863 pp | 19.17% +19.167 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 12 | NEUBERGER BERMAN GROUP LLC | 3.64M -241.0K (-6.2%) | 297.32M +31.4M (+11.8%) | 1.82% -0.115 pp | 0.22% +0.027 pp | USD85.75 -4.4% | 8 qtrs — |
| 13 | JANA PARTNERS MANAGEMENT, LP | 3.52M +1.1M (+44.6%) | 288.47M +121.6M (+72.8%) | 1.76% +0.546 pp | 15.01% +6.929 pp | USD72.69 +12.8% | 2 qtrs — |
| 14 | SUSTAINABLE GROWTH ADVISERS, LP | 3.37M -764.0K (-18.5%) | 276.09M -7.2M (-2.6%) | 1.68% -0.376 pp | 1.91% +0.256 pp | USD70.69 +15.9% | 3 qtrs — |
| 15 | DIAMOND HILL CAPITAL MANAGEMENT INC | 3.29M +2.7M (+479.6%) | 269.47M +230.6M (+592.9%) | 1.66% +1.377 pp | 1.38% +1.196 pp | USD79.65 +2.9% | 2 qtrs — |
| 16 | INVESCO LTD. | 3.16M -1.3M (-28.4%) | 259.40M -43.6M (-14.4%) | 1.60% -0.605 pp | 0.04% -0.008 pp | USD98.27 -16.6% | 8 qtrs — |
| 17 | JANUS HENDERSON GROUP PLC | 3.11M -316.8K (-9.3%) | 254.60M +19.9M (+8.5%) | 1.57% -0.138 pp | 0.11% +0.007 pp | USD93.35 -12.2% | 8 qtrs — |
| 18 | GENERATION INVESTMENT MANAGEMENT LLP | 2.85M +2.8M (+100.0%) | 233.54M +233.5M (+100.0%) | 1.42% +1.425 pp | 1.62% +1.620 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 19 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.82M -283.9K (-9.2%) | 230.78M +18.3M (+8.6%) | 1.42% -0.124 pp | 0.07% +0.009 pp | USD82.67 -0.9% | 8 qtrs — |
| 20 | UBS ASSET MANAGEMENT AMERICAS INC | 2.56M -99.2K (-3.7%) | 210.07M +27.5M (+15.1%) | 1.28% -0.046 pp | 0.04% +0.005 pp | USD89.63 -8.6% | 8 qtrs — |
| 21 | ALLIANCEBERNSTEIN L.P. | 2.24M -947.2K (-29.7%) | 183.87M -34.9M (-15.9%) | 1.12% -0.469 pp | 0.06% -0.011 pp | USD99.24 -17.4% | 8 qtrs — |
| 22 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.11M +1.4M (+214.7%) | 172.83M +126.9M (+276.2%) | 1.05% +0.720 pp | 0.10% +0.072 pp | USD83.05 -1.3% | 6 qtrs — |
| 23 | LONDON CO OF VIRGINIA | 2.07M +2.1M (+100.0%) | 170.02M +170.0M (+100.0%) | 1.04% +1.037 pp | 0.98% +0.981 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 24 | MORGAN STANLEY | 2.01M -103.6K (-4.9%) | 164.55M +19.8M (+13.7%) | 1.01% -0.039 pp | 0.01% +0.001 pp | USD93.74 -12.6% | 8 qtrs — |
| 25 | DIMENSIONAL FUND ADVISORS LP | 1.96M +198.9K (+11.3%) | 160.63M +39.9M (+33.1%) | 0.99% +0.112 pp | 0.03% +0.008 pp | USD92.70 -11.6% | 8 qtrs — |
| 26 | NORTHERN TRUST CORP | 1.83M +44.4K (+2.5%) | 150.38M +27.6M (+22.5%) | 0.93% +0.034 pp | 0.02% +0.004 pp | USD97.45 -15.9% | 8 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.77M +27.0K (+1.5%) | 145.26M +25.6M (+21.4%) | 0.89% +0.016 pp | 0.02% +0.004 pp | USD88.55 -7.4% | 8 qtrs — |
| 28 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 1.77M -179.1K (-9.2%) | 145.05M +11.4M (+8.6%) | 0.88% -0.087 pp | 1.47% +0.461 pp | USD95.59 -14.3% | 8 qtrs — |
| 29 | UBS GROUP AG | 1.76M -899.6K (-33.8%) | 144.29M -38.1M (-20.9%) | 0.89% -0.437 pp | 0.02% -0.005 pp | USD85.28 -3.9% | 8 qtrs — |
| 30 | AQR CAPITAL MANAGEMENT LLC | 1.65M +1.2M (+247.1%) | 135.54M +103.0M (+316.0%) | 0.83% +0.597 pp | 0.07% +0.050 pp | USD80.34 +2.0% | 8 qtrs — |
| 31 | RIVER ROAD ASSET MANAGEMENT, LLC | 1.58M +16.1K (+1.0%) | 129.73M +22.3M (+20.8%) | 0.80% +0.018 pp | 1.42% +0.219 pp | USD69.64 +17.7% | 3 qtrs — |
| 32 | MANNING & NAPIER ADVISORS LLC | 1.56M +1.6M (+100.0%) | 128.99M +129.0M (+100.0%) | 0.79% +0.790 pp | 1.68% +1.675 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 33 | ALECTA TJANSTEPENSION OMSESIDIGT | 1.56M +— (+0.0%) | 128.07M +21.0M (+19.6%) | 0.79% +0.010 pp | 0.56% +0.085 pp | USD80.50 +1.8% | 5 qtrs — |
| 34 | FINDLAY PARK PARTNERS LLP | 1.48M -301.1K (-16.9%) | 121.49M -780.6K (-0.6%) | 0.74% -0.148 pp | 1.55% +0.266 pp | USD74.36 +10.2% | 4 qtrs — |
| 35 | BANK OF AMERICA CORP /DE/ | 1.46M -481.0K (-24.8%) | 119.71M -13.4M (-10.1%) | 0.74% -0.231 pp | 0.01% 0.000 pp | USD90.05 -9.0% | 8 qtrs — |
| 36 | WELLS FARGO & COMPANY/MN | 1.35M +149.5K (+12.4%) | 110.87M +28.4M (+34.4%) | 0.68% +0.083 pp | 0.02% +0.005 pp | USD97.40 -15.9% | 8 qtrs — |
| 37 | COLONY GROUP, LLC | 1.29M +1.3M (+39,754.6%) | 106.06M +105.8M (+48,425.8%) | 0.65% +0.645 pp | 0.12% +0.121 pp | USD81.93 +0.0% | 3 qtrs — |
| 38 | BOSTON TRUST WALDEN CORP | 1.24M -257.5K (-17.2%) | 101.42M -1.1M (-1.0%) | 0.62% -0.121 pp | 0.77% +0.014 pp | USD97.06 -15.6% | 8 qtrs — |
| 39 | NATIONAL BANK OF CANADA /FI/ | 1.13M +1.0M (+1,141.5%) | 92.56M +86.3M (+1,384.2%) | 0.57% +0.525 pp | 0.08% +0.078 pp | USD82.53 -0.7% | 8 qtrs — |
| 40 | BANK OF NEW YORK MELLON CORP | 1.13M -21.9K (-1.9%) | 92.44M +13.6M (+17.3%) | 0.56% -0.009 pp | 0.02% +0.001 pp | USD99.24 -17.4% | 8 qtrs — |
| 41 | SWEDBANK AB | 1.07M +170.0K (+18.8%) | 88.03M +26.0M (+42.0%) | 0.54% +0.086 pp | 0.09% +0.022 pp | USD94.40 -13.2% | 8 qtrs — |
| 42 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 979.7K -5.3K (-0.5%) | 80.30M +12.8M (+18.9%) | 0.49% -0.001 pp | 0.07% +0.011 pp | USD94.54 -13.3% | 8 qtrs — |
| 43 | LEGAL & GENERAL GROUP PLC | 937.7K -339.8K (-26.6%) | 76.86M -10.7M (-12.3%) | 0.47% -0.168 pp | 0.02% -0.003 pp | USD98.19 -16.5% | 8 qtrs — |
| 44 | BESSEMER GROUP INC | 908.4K -433.3K (-32.3%) | 74.46M -17.5M (-19.1%) | 0.46% -0.210 pp | 0.11% -0.026 pp | USD99.08 -17.3% | 8 qtrs — |
| 45 | AMUNDI | 827.1K +44.0K (+5.6%) | 67.79M +12.9M (+23.5%) | 0.41% +0.023 pp | 0.02% +0.001 pp | USD86.35 -5.1% | 8 qtrs — |
| 46 | SG AMERICAS SECURITIES, LLC | 820.2K +813.5K (+12,167.2%) | 67.22M +66.8M (+14,577.3%) | 0.41% +0.411 pp | 0.09% +0.084 pp | USD81.98 0.0% | 8 qtrs — |
| 47 | GOLDMAN SACHS GROUP INC | 795.0K +286.4K (+56.3%) | 65.16M +30.3M (+86.9%) | 0.40% +0.148 pp | 0.01% +0.004 pp | USD86.37 -5.1% | 7 qtrs — |
| 48 | RAYMOND JAMES FINANCIAL INC | 778.5K -29.3K (-3.6%) | 63.80M +8.4M (+15.2%) | 0.39% -0.010 pp | 0.02% +0.002 pp | USD89.35 -8.3% | 5 qtrs — |
| 49 | ARROWMARK COLORADO HOLDINGS LLC | 764.7K -386.8K (-33.6%) | 62.68M -16.3M (-20.6%) | 0.38% -0.192 pp | 1.38% -0.087 pp | USD91.09 -10.0% | 8 qtrs — |
| 50 | NUVEEN, LLC | 753.7K +65.0K (+9.4%) | 61.78M +14.6M (+30.8%) | 0.38% +0.037 pp | 0.02% +0.004 pp | USD83.30 -1.6% | 4 qtrs — |
| 51 | JPMORGAN CHASE & CO | 711.7K -664.8K (-48.3%) | 58.33M -36.0M (-38.2%) | 0.36% -0.327 pp | 0.00% -0.002 pp | USD98.65 -16.9% | 8 qtrs — |
| 52 | TD ASSET MANAGEMENT INC | 700.0K -58.7K (-7.7%) | 57.37M +5.4M (+10.3%) | 0.35% -0.028 pp | 0.05% +0.004 pp | USD85.17 -3.8% | 7 qtrs — |
| 53 | ENVESTNET ASSET MANAGEMENT INC | 699.4K +51.6K (+8.0%) | 57.32M +12.9M (+29.1%) | 0.35% +0.030 pp | 0.02% +0.004 pp | USD97.31 -15.8% | 8 qtrs — |
| 54 | DEUTSCHE BANK AG\ | 676.5K -55.1K (-7.5%) | 55.44M +5.3M (+10.5%) | 0.34% -0.023 pp | 0.02% +0.001 pp | USD98.49 -16.8% | 8 qtrs — |
| 55 | BAMCO INC /NY/ | 664.5K +753.0 (+0.1%) | 54.46M +9.0M (+19.7%) | 0.34% +0.005 pp | 0.15% +0.027 pp | USD99.16 -17.3% | 8 qtrs — |
| 56 | RATHBONES GROUP PLC | 599.0K -12.7K (-2.1%) | 49.09M +7.2M (+17.1%) | 0.30% -0.005 pp | 0.19% +0.024 pp | USD97.46 -15.9% | 8 qtrs — |
| 57 | DAVENPORT & CO LLC | 567.2K +528.3K (+1,359.7%) | 46.64M +44.0M (+1,650.8%) | 0.29% +0.267 pp | 0.25% +0.234 pp | USD81.27 +0.8% | 8 qtrs — |
| 58 | SWISS NATIONAL BANK | 543.7K -31.4K (-5.5%) | 44.56M +5.1M (+13.0%) | 0.27% -0.015 pp | 0.03% +0.004 pp | USD97.30 -15.8% | 8 qtrs — |
| 59 | MACKENZIE FINANCIAL CORP | 527.7K +14.1K (+2.7%) | 43.43M +8.2M (+23.4%) | 0.26% +0.008 pp | 0.05% +0.009 pp | USD70.39 +16.4% | 8 qtrs — |
| 60 | MACQUARIE GROUP LTD | 513.4K -933.5K (-64.5%) | 42.08M -57.1M (-57.6%) | 0.26% -0.465 pp | 0.18% +0.068 pp | USD98.62 -16.9% | 8 qtrs — |
| 61 | MILLENNIUM MANAGEMENT LLC | 508.0K -1.7M (-76.7%) | 41.64M -107.7M (-72.1%) | 0.26% -0.829 pp | 0.02% -0.046 pp | USD98.04 -16.4% | 8 qtrs — |
| 62 | BALYASNY ASSET MANAGEMENT L.P. | 495.9K +385.3K (+348.3%) | 40.64M +33.1M (+436.0%) | 0.25% +0.195 pp | 0.05% +0.042 pp | USD82.49 -0.6% | 8 qtrs — |
| 63 | TUDOR INVESTMENT CORP ET AL | 465.5K +465.5K (+100.0%) | 38.15M +38.2M (+100.0%) | 0.24% +0.235 pp | 0.07% +0.071 pp | USD81.96 +0.0% | 8 qtrs — |
| 64 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 433.2K -29.9K (-6.5%) | 35.51M +3.8M (+11.8%) | 0.22% -0.012 pp | 0.02% +0.003 pp | USD98.48 -16.8% | 8 qtrs — |
| 65 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 421.9K +23.9K (+6.0%) | 34.22M +6.9M (+25.4%) | 0.21% +0.015 pp | 0.02% +0.004 pp | USD92.93 -11.8% | 8 qtrs — |
| 66 | ROYAL BANK OF CANADA | 415.6K -373.8K (-47.4%) | 34.06M -20.1M (-37.1%) | 0.21% -0.184 pp | 0.01% -0.003 pp | USD86.68 -5.4% | 8 qtrs — |
| 67 | NORGES BANK | 405.2K +405.2K (+100.0%) | 33.21M +33.2M (+100.0%) | 0.20% +0.203 pp | 0.00% +0.004 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 68 | AMERIPRISE FINANCIAL INC | 402.4K -2.1M (-83.9%) | 32.98M -138.0M (-80.7%) | 0.20% -1.040 pp | 0.01% -0.032 pp | USD85.12 -3.7% | 8 qtrs — |
| 69 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 399.2K -70.8K (-15.1%) | 32.72M +492.2K (+1.5%) | 0.20% -0.033 pp | 0.02% -0.001 pp | USD98.19 -16.5% | 8 qtrs — |
| 70 | FMR LLC | 395.6K +188.3K (+90.8%) | 32.42M +18.2M (+128.1%) | 0.20% +0.096 pp | 0.00% +0.001 pp | USD89.05 -8.0% | 8 qtrs — |
| 71 | RHUMBLINE ADVISERS | 380.0K -15.4K (-3.9%) | 31.15M +4.0M (+14.9%) | 0.19% -0.005 pp | 0.03% +0.003 pp | USD97.39 -15.8% | 8 qtrs — |
| 72 | FRONTIER CAPITAL MANAGEMENT CO LLC | 361.3K +42.6K (+13.4%) | 29.61M +7.8M (+35.5%) | 0.18% +0.022 pp | 0.31% +0.118 pp | USD91.04 -10.0% | 8 qtrs — |
| 73 | HSBC HOLDINGS PLC | 359.3K -50.1K (-12.2%) | 29.46M +1.4M (+5.1%) | 0.18% -0.023 pp | 0.02% 0.000 pp | USD94.34 -13.1% | 8 qtrs — |
| 74 | BARCLAYS PLC | 339.1K -123.9K (-26.8%) | 27.79M -23.3M (-45.6%) | 0.17% -0.060 pp | 0.01% -0.006 pp | USD90.30 -9.2% | 8 qtrs — |
| 75 | KBC GROUP NV | 335.0K -5.1K (-1.5%) | 27.46M +4.1M (+17.7%) | 0.17% 0.000 pp | 0.06% +0.007 pp | USD91.88 -10.8% | 8 qtrs — |
| 76 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 327.5K +90.5K (+38.2%) | 26.84M +10.6M (+65.2%) | 0.16% +0.046 pp | 2.51% +0.711 pp | USD84.13 -2.6% | 8 qtrs — |
| 77 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 325.0K +230.0K (+242.1%) | 26.64M +20.1M (+309.0%) | 0.16% +0.117 pp | 1.32% +0.882 pp | USD78.60 +4.3% | 8 qtrs — |
| 78 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 321.4K -11.2K (-3.4%) | 26.34M +3.5M (+15.5%) | 0.16% -0.004 pp | 0.03% +0.003 pp | USD97.24 -15.7% | 8 qtrs — |
| 79 | CRAMER ROSENTHAL MCGLYNN LLC | 317.2K +207.8K (+190.1%) | 25.99M +18.5M (+246.8%) | 0.16% +0.104 pp | 1.68% +1.209 pp | USD77.34 +6.0% | 2 qtrs — |
| 80 | RUFFER LLP | 312.2K -1.0M (-76.8%) | 25.62M -66.8M (-72.3%) | 0.16% -0.514 pp | 1.17% -3.970 pp | USD69.04 +18.7% | 3 qtrs — |
| 81 | NATIXIS ADVISORS, L.P. | 303.5K +270.5K (+820.1%) | 24.87M +22.6M (+1,000.0%) | 0.15% +0.135 pp | 0.04% +0.032 pp | USD83.77 -2.2% | 8 qtrs — |
| 82 | WEISS ASSET MANAGEMENT LP | 294.6K +138.5K (+88.8%) | 24.12M +13.4M (+125.4%) | 0.15% +0.070 pp | 0.34% +0.212 pp | USD74.86 +9.5% | 2 qtrs — |
| 83 | WOODLINE PARTNERS LP | 294.0K +4.1K (+1.4%) | 24.09M +4.2M (+21.2%) | 0.15% +0.003 pp | 0.09% 0.000 pp | USD95.98 -14.6% | 8 qtrs — |
| 84 | BELLEVUE GROUP AG | 292.0K -306.0 (-0.1%) | 23.93M +3.9M (+19.4%) | 0.15% +0.000 pp | 0.45% +0.037 pp | USD99.24 -17.4% | 8 qtrs — |
| 85 | SEI INVESTMENTS CO | 285.4K -231.6K (-44.8%) | 23.40M -12.1M (-34.0%) | 0.14% -0.115 pp | 0.02% -0.015 pp | USD89.15 -8.1% | 8 qtrs — |
| 86 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 275.8K -535.0 (-0.2%) | 22.61M +3.7M (+19.3%) | 0.14% +0.002 pp | 0.09% +0.015 pp | USD99.38 -17.5% | 8 qtrs — |
| 87 | ASSENAGON ASSET MANAGEMENT S.A. | 271.3K +265.2K (+4,342.5%) | 22.24M +21.8M (+5,210.8%) | 0.14% +0.134 pp | 0.03% +0.030 pp | USD82.19 -0.3% | 8 qtrs — |
| 88 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 263.3K -74.2K (-22.0%) | 21.58M -1.6M (-6.7%) | 0.13% -0.037 pp | 0.33% -0.034 pp | USD68.56 +19.5% | 2 qtrs — |
| 89 | BNP PARIBAS ARBITRAGE, SNC | 262.3K +6.4K (+2.5%) | 21.50M +4.0M (+22.5%) | 0.13% +0.005 pp | 0.01% +0.000 pp | USD91.66 -10.6% | 8 qtrs — |
| 90 | CITIGROUP INC | 251.1K -82.8K (-24.8%) | 20.58M -2.3M (-10.1%) | 0.13% -0.041 pp | 0.01% -0.001 pp | USD80.33 +2.0% | 8 qtrs — |
| 91 | TRIODOS INVESTMENT MANAGEMENT BV | 248.3K -1.5K (-0.6%) | 20.47M +3.4M (+19.6%) | 0.13% +0.001 pp | 1.48% +0.242 pp | USD80.70 +1.6% | 8 qtrs — |
| 92 | STIFEL FINANCIAL CORP | 248.6K +19.8K (+8.6%) | 20.38M +4.7M (+29.9%) | 0.12% +0.010 pp | 0.02% +0.004 pp | USD97.40 -15.9% | 8 qtrs — |
| 93 | GOTHAM ASSET MANAGEMENT, LLC | 243.6K +127.8K (+110.3%) | 19.97M +12.0M (+151.5%) | 0.12% +0.064 pp | 0.07% +0.038 pp | USD76.15 +7.6% | 5 qtrs — |
| 94 | CONGRESS ASSET MANAGEMENT CO /MA | 232.9K -219.4K (-48.5%) | 19.09M -11.9M (-38.4%) | 0.12% -0.108 pp | 0.13% -0.072 pp | USD97.94 -16.3% | 9 qtrs — |
| 95 | BANK OF NOVA SCOTIA | 231.1K +206.6K (+841.1%) | 18.94M +17.3M (+1,025.0%) | 0.12% +0.103 pp | 0.03% +0.025 pp | USD84.51 -3.0% | 8 qtrs — |
| 96 | MARINER, LLC | 223.4K +42.7K (+23.7%) | 18.31M +5.9M (+47.9%) | 0.11% +0.022 pp | 0.02% +0.006 pp | USD76.33 +7.4% | 8 qtrs — |
| 97 | PRINCIPAL FINANCIAL GROUP INC | 219.4K +4.6K (+2.1%) | 17.98M +3.3M (+22.1%) | 0.11% +0.004 pp | 0.01% +0.002 pp | USD99.55 -17.7% | 8 qtrs — |
| 98 | TRAJAN WEALTH LLC | 207.5K +28.3K (+15.8%) | 17.01M +4.7M (+38.4%) | 0.10% +0.014 pp | 0.71% +0.178 pp | USD70.39 +16.4% | 2 qtrs — |
| 99 | MKP CAPITAL MANAGEMENT, L.L.C. | 200.0K +200.0K (+100.0%) | 16.39M +16.4M (+100.0%) | 0.10% +0.100 pp | 0.58% +0.584 pp | USD81.96 +0.0% | 1 qtrs NEW |
| 100 | CLEARBRIDGE INVESTMENTS, LLC | 193.3K -131.4K (-40.5%) | 15.84M -6.4M (-28.8%) | 0.10% -0.065 pp | 0.01% -0.004 pp | USD95.27 -14.0% | 8 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | WEISS ROBERT S | Director | M-Exempt | D | Restricted Stock Units | 3,654 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Rosebrough Walter M Jr | Director | M-Exempt | A | Common Stock | 832 | 0.00 | — | 832 | D | ↗ |
| 2026-04-01 | Rivas Maria | Director | M-Exempt | D | Restricted Stock Units | 3,322 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | MADDEN TERESA S | Director | M-Exempt | D | Restricted Stock Units | 3,322 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Lucchese Cynthia L | Director | M-Exempt | D | Restricted Stock Units | 3,322 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Kurzius Lawrence Erik | Director | A-Award | A | Restricted Stock Units | 3,779 | 0.00 | — | 3,779 | D | ↗ |
| 2026-04-01 | Jay Colleen | Director | M-Exempt | D | Restricted Stock Units | 3,322 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Carbone Barbara | Director | A-Award | A | Restricted Stock Units | 3,779 | 0.00 | — | 3,779 | D | ↗ |
| 2026-02-18 | McCuin Robert | Officer | — | — | Option (Right to Buy) | 14,109 | 5.69 | 80.3K | 0 | D | ↗ |
| 2026-01-12 | Jay Colleen | Director | M-Exempt | A | Common Stock | 7,064 | 39.40 | 278.3K | 36,585 | D | ↗ |
| 2026-01-08 | White Albert G III | Director / Officer | M-Exempt | A | Common Stock | 18,340 | 0.00 | — | 254,491 | D | ↗ |
| 2026-01-08 | Warner Gerard H III | Officer | M-Exempt | A | Common Stock | 1,540 | 0.00 | — | 29,837 | D | ↗ |
| 2026-01-08 | Sheffield Holly R | Officer | F-InKind | D | Common Stock | 738 | 83.13 | 61.3K | 44,902 | D | ↗ |
| 2026-01-08 | McBride Daniel G | Officer | F-InKind | D | Common Stock | 2,415 | 83.13 | 200.8K | 73,592 | D | ↗ |
| 2026-01-08 | Andrews Brian G | Officer | F-InKind | D | Common Stock | 1,893 | 83.13 | 157.4K | 8,537 | D | ↗ |
| 2026-01-03 | Rosebrough Walter M Jr | Director | — | — | Common Stock | 0 | 0.00 | — | 10,000 | I | ↗ |
| 2025-12-22 | Lucchese Cynthia L | Director | P-Purchase | A | Common Stock | 1,784 | 84.06 | 150.0K | 9,445 | D | ↗ |
| 2025-12-18 | Rivas Maria | Director | P-Purchase | A | Common Stock | 1,000 | 82.13 | 82.1K | 11,141 | I | ↗ |
| 2025-12-17 | Kurzius Lawrence Erik | Director | P-Purchase | A | Common Stock | 2,000 | 82.50 | 165.0K | 7,777 | D | ↗ |
| 2025-12-16 | White Albert G III | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 80.80 | 808.0K | 236,151 | D | ↗ |
| 2025-12-16 | Sheffield Holly R | Officer | P-Purchase | A | Common Stock | 1,230 | 80.75 | 99.3K | 39,052 | D | ↗ |
| 2025-12-12 | WEISS ROBERT S | Director | G-Gift | D | Common Stock | 7,500 | 0.00 | — | 257,860 | I | ↗ |
| 2025-12-09 | White Albert G III | Director / Officer | A-Award | A | Restricted Stock Units | 84,613 | 0.00 | — | 84,613 | D | ↗ |
| 2025-12-09 | Warner Gerard H III | Officer | A-Award | A | Restricted Stock Units | 15,921 | 0.00 | — | 15,921 | D | ↗ |
| 2025-12-09 | Sheffield Holly R | Officer | A-Award | A | Restricted Stock Units | 15,921 | 0.00 | — | 15,921 | D | ↗ |
| 2025-12-09 | McBride Daniel G | Officer | A-Award | A | Restricted Stock Units | 21,016 | 0.00 | — | 21,016 | D | ↗ |
| 2025-12-09 | Andrews Brian G | Officer | A-Award | A | Restricted Stock Units | 19,105 | 0.00 | — | 19,105 | D | ↗ |
| 2025-09-29 | Kurzius Lawrence Erik | Director | P-Purchase | A | Common Stock | 2,000 | 68.39 | 136.8K | 5,777 | D | ↗ |
| 2025-09-05 | White Albert G III | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 68.39 | 683.9K | 226,151 | D | ↗ |
| 2025-09-05 | Warner Gerard H III | Officer | P-Purchase | A | Common Stock | 1,450 | 69.23 | 100.4K | 18,319 | D | ↗ |
| 2025-09-02 | McBride Daniel G | Officer | P-Purchase | A | Common Stock | 3,000 | 65.04 | 195.1K | 63,120 | D | ↗ |
| 2025-09-02 | Andrews Brian G | Officer | P-Purchase | A | Common Stock | 1,525 | 65.68 | 100.2K | 22,191 | I | ↗ |
| 2025-05-01 | Carbone Barbara | Director | A-Award | A | Restricted Stock Units | 3,050 | 0.00 | — | 3,050 | D | ↗ |
| 2025-04-01 | WEISS ROBERT S | Director | M-Exempt | D | Restricted Stock Units | 2,993 | 0.00 | — | 0 | D | ↗ |
| 2025-04-01 | Rivas Maria | Director | A-Award | A | Restricted Stock Units | 3,322 | 0.00 | — | 3,322 | D | ↗ |
| 2025-04-01 | Ricupati Agostino | Officer | M-Exempt | A | Common Stock | 2,076 | 0.00 | — | 9,044 | D | ↗ |
| 2025-04-01 | MADDEN TERESA S | Director | M-Exempt | D | Restricted Stock Units | 2,721 | 0.00 | — | 0 | D | ↗ |
| 2025-04-01 | Lucchese Cynthia L | Director | M-Exempt | D | Restricted Stock Units | 2,721 | 0.00 | — | 0 | D | ↗ |
| 2025-04-01 | Kurzius Lawrence Erik | Director | M-Exempt | A | Common Stock | 2,721 | 0.00 | — | 3,777 | D | ↗ |
| 2025-04-01 | KOZY WILLIAM A | Director | M-Exempt | A | Common Stock | 2,857 | 0.00 | — | 31,149 | D | ↗ |
| 2025-04-01 | Jay Colleen | Director | M-Exempt | A | Common Stock | 2,721 | 0.00 | — | 29,521 | D | ↗ |
| 2025-02-01 | White Albert G III | Director / Officer | M-Exempt | D | Performance Stock Unit | 84,264 | 0.00 | — | 0 | D | ↗ |
| 2025-02-01 | Sheffield Holly R | Officer | F-InKind | D | Common Stock | 8,021 | 96.55 | 774.4K | 37,822 | D | ↗ |
| 2025-02-01 | McBride Daniel G | Officer | F-InKind | D | Common Stock | 11,567 | 96.55 | 1.12M | 60,120 | D | ↗ |
| 2025-02-01 | Andrews Brian G | Officer | M-Exempt | D | Performance Stock Unit | 16,850 | 0.00 | — | 0 | D | ↗ |
| 2025-01-08 | White Albert G III | Director / Officer | M-Exempt | A | Common Stock | 18,340 | 0.00 | — | 183,613 | D | ↗ |
| 2025-01-08 | Warner Gerard H III | Officer | M-Exempt | A | Common Stock | 1,536 | 0.00 | — | 17,343 | D | ↗ |
| 2025-01-08 | Sheffield Holly R | Officer | M-Exempt | D | Restricted Stock Units | 1,592 | 0.00 | — | 3,184 | D | ↗ |
| 2025-01-08 | Ricupati Agostino | Officer | F-InKind | D | Common Stock | 1,283 | 91.88 | 117.9K | 6,968 | D | ↗ |
| 2025-01-08 | McBride Daniel G | Officer | M-Exempt | A | Common Stock | 4,172 | 0.00 | — | 48,868 | D | ↗ |
| 2025-01-08 | Khadder Nicholas | Officer | M-Exempt | D | Restricted Stock Units | 1,140 | 0.00 | — | 2,272 | D | ↗ |
| 2025-01-08 | Andrews Brian G | Officer | M-Exempt | A | Common Stock | 3,528 | 0.00 | — | 13,034 | D | ↗ |
| 2024-12-10 | White Albert G III | Director / Officer | A-Award | A | Performance Stock Units | 84,264 | 0.00 | — | 84,264 | D | ↗ |
| 2024-12-10 | Warner Gerard H III | Officer | A-Award | A | Restricted Stock Units | 12,616 | 0.00 | — | 12,616 | D | ↗ |
| 2024-12-10 | Sheffield Holly R | Officer | A-Award | A | Restricted Stock Units | 12,616 | 0.00 | — | 12,616 | D | ↗ |
| 2024-12-10 | Ricupati Agostino | Officer | A-Award | A | Restricted Stock Units | 8,074 | 0.00 | — | 8,074 | D | ↗ |
| 2024-12-10 | McBride Daniel G | Officer | A-Award | A | Restricted Stock Units | 16,653 | 0.00 | — | 16,653 | D | ↗ |
| 2024-12-10 | Khadder Nicholas | Officer | A-Award | A | Restricted Stock Units | 8,578 | 0.00 | — | 8,578 | D | ↗ |
| 2024-12-10 | Andrews Brian G | Officer | A-Award | A | Stock Options (Right to Buy) | 46,928 | 99.08 | 4.65M | 46,928 | D | ↗ |
| 2024-09-19 | White Albert G III | Director / Officer | M-Exempt | A | Common Stock | 114,992 | 43.83 | 5.04M | 280,265 | D | ↗ |
| 2024-09-10 | Ricupati Agostino | Officer | S-Sale | D | Common Stock | 1,601 | 108.03 | 173.0K | 4,818 | — | ↗ |
| 2024-09-05 | Andrews Brian G | Officer | M-Exempt | A | Common Stock | 11,364 | 43.83 | 498.1K | 31,402 | — | ↗ |
| 2024-09-04 | McBride Daniel G | Officer | M-Exempt | D | Stock Option (Right to Buy) | 114,992 | 43.83 | 5.04M | 0 | — | ↗ |
| 2024-04-01 | WEISS ROBERT S | Director | A-Award | A | Restricted Stock Units | 2,993 | 0.00 | — | 2,993 | — | ↗ |
| 2024-04-01 | Rivas Maria | Director | M-Exempt | A | Common Stock | 2,892 | 0.00 | — | 2,892 | — | ↗ |
| 2024-04-01 | Ricupati Agostino | Officer | M-Exempt | A | Common Stock | 2,076 | 0.00 | — | 7,472 | — | ↗ |
| 2024-04-01 | MADDEN TERESA S | Director | M-Exempt | D | Restricted Stock Units | 2,892 | 0.00 | — | 0 | — | ↗ |
| 2024-04-01 | Lucchese Cynthia L | Director | A-Award | A | Restricted Stock Units | 2,721 | 0.00 | — | 2,721 | — | ↗ |
| 2024-04-01 | Kurzius Lawrence Erik | Director | M-Exempt | D | Restricted Stock Units | 1,056 | 0.00 | — | 0 | — | ↗ |
| 2024-04-01 | KOZY WILLIAM A | Director | M-Exempt | A | Common Stock | 3,036 | 0.00 | — | 28,292 | — | ↗ |
| 2024-04-01 | Jay Colleen | Director | M-Exempt | D | Restricted Stock Units | 2,892 | 0.00 | — | 0 | — | ↗ |
| 2024-03-22 | PETERSMEYER GARY S | Director | G-Gift | D | Common Stock | 655 | 0.00 | — | 5,013 | — | ↗ |
| 2024-03-18 | Ricupati Agostino | Officer | M-Exempt | A | Common Stock | 52 | 40.57 | 2.1K | 5,133 | — | ↗ |
| 2024-03-13 | WEISS ROBERT S | Director | G-Gift | D | Common Stock | 30,000 | 0.00 | — | 265,360 | — | ↗ |
| 2024-03-08 | WEISS ROBERT S | Director | M-Exempt | A | Common Stock | 88,075 | 57.42 | 5.06M | 370,847 | — | ↗ |
| 2024-03-07 | WEISS ROBERT S | Director | S-Sale | D | Common Stock | 153,213 | 102.21 | 15.66M | 282,772 | — | ↗ |
| 2024-03-07 | Rivas Maria | Director | G-Gift | A | Common Stock | 4,528 | 0.00 | — | 4,528 | — | ↗ |
| 2024-03-05 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 1,000 | 103.51 | 103.5K | 5,668 | — | ↗ |
| 2024-03-01 | Sailer David | Officer | — | D | Common Stock | 0 | 0.00 | — | 514,624 | — | ↗ |
| 2024-01-08 | Warner Gerard H III | Officer | F-InKind | D | Common Stock | 139 | 373.57 | 51.9K | 3,726 | — | ↗ |
| 2024-01-08 | Sheffield Holly R | Officer | F-InKind | D | Common Stock | 206 | 373.57 | 77.0K | 5,233 | — | ↗ |
| 2024-01-08 | Ricupati Agostino | Officer | F-InKind | D | Common Stock | 208 | 373.57 | 77.7K | 1,413 | — | ↗ |
| 2024-01-08 | McBride Daniel G | Officer | M-Exempt | D | Restricted Stock Units | 1,042 | 0.00 | — | 3,127 | — | ↗ |
| 2024-01-08 | Khadder Nicholas | Officer | F-InKind | D | Common Stock | 157 | 373.57 | 58.7K | 168 | — | ↗ |
| 2024-01-08 | Andrews Brian G | Officer | M-Exempt | A | Common Stock | 723 | 0.00 | — | 2,996 | — | ↗ |
| 2024-01-04 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 150 | 336.03 | 50.4K | 2,297 | — | ↗ |
| 2023-12-21 | PETERSMEYER GARY S | Director | G-Gift | D | Common Stock | 17 | 0.00 | — | 2,447 | — | ↗ |
| 2023-12-19 | WEISS ROBERT S | Director | S-Sale | D | Common Stock | 29,272 | 365.51 | 10.70M | 71,631 | — | ↗ |
| 2023-12-14 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 300 | 368.55 | 110.6K | 2,464 | — | ↗ |
| 2023-12-13 | McBride Daniel G | Officer | G-Gift | D | Common Stock | 300 | 0.00 | — | 8,326 | — | ↗ |
| 2023-12-12 | White Albert G III | Director / Officer | A-Award | A | Restricted Stock Units | 18,339 | 0.00 | — | 18,339 | — | ↗ |
| 2023-12-12 | Warner Gerard H III | Officer | A-Award | A | Restricted Stock Units | 2,939 | 0.00 | — | 2,939 | — | ↗ |
| 2023-12-12 | Sheffield Holly R | Officer | A-Award | A | Restricted Stock Units | 3,306 | 0.00 | — | 3,306 | — | ↗ |
| 2023-12-12 | Ricupati Agostino | Officer | A-Award | A | Restricted Stock Units | 2,351 | 0.00 | — | 2,351 | — | ↗ |
| 2023-12-12 | McBride Daniel G | Officer | A-Award | A | Restricted Stock Units | 4,555 | 0.00 | — | 4,555 | — | ↗ |
| 2023-12-12 | Khadder Nicholas | Officer | A-Award | A | Restricted Stock Units | 2,351 | 0.00 | — | 2,351 | — | ↗ |
| 2023-12-12 | Andrews Brian G | Officer | A-Award | A | Restricted Stock Units | 3,527 | 0.00 | — | 3,527 | — | ↗ |
| 2023-12-01 | Kurzius Lawrence Erik | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-22 | McBride Daniel G | Officer | G-Gift | D | Common Stock | 23,624 | 0.00 | — | 8,560 | — | ↗ |
| 2023-06-04 | Sheffield Holly R | Officer | M-Exempt | A | Common Stock | 1,104 | 356.47 | 393.5K | 4,952 | — | ↗ |
| 2023-04-01 | WEISS ROBERT S | Director | M-Exempt | A | Common Stock | 693 | 0.00 | — | 70,693 | — | ↗ |
| 2023-04-01 | Rivas Maria | Director | M-Exempt | D | Restricted Stock Units | 630 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | PETERSMEYER GARY S | Director | M-Exempt | D | Restricted Stock Units | 630 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | MADDEN TERESA S | Director | M-Exempt | D | Restricted Stock Units | 630 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | Lucchese Cynthia L | Director | M-Exempt | D | Restricted Stock Units | 512 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | KOZY WILLIAM A | Director | M-Exempt | D | Restricted Stock Units | 662 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | Jay Colleen | Director | M-Exempt | A | Common Stock | 630 | 0.00 | — | 5,977 | — | ↗ |
| 2023-03-31 | Ricupati Agostino | Officer | S-Sale | D | Common Stock | 1,000 | 370.00 | 370.0K | 863 | — | ↗ |
| 2023-03-15 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 700 | 335.78 | 235.0K | 2,134 | — | ↗ |
| 2023-03-09 | Warner Gerard H III | Officer | S-Sale | D | Common Stock | 1,216 | 340.53 | 414.1K | 1,290 | — | ↗ |
| 2023-03-09 | PETERSMEYER GARY S | Director | G-Gift | D | Common Stock | 75 | 0.00 | — | 2,834 | — | ↗ |
| 2023-03-07 | WEISS ROBERT S | Director | S-Sale | D | Common Stock | 4,084 | 340.48 | 1.39M | 73,504 | — | ↗ |
| 2023-01-08 | Warner Gerard H III | Director | M-Exempt | D | Restricted Stock Units | 541 | 0.00 | — | 1,084 | — | ↗ |
| 2023-01-08 | Sheffield Holly R | Director | M-Exempt | A | Common Stock | 589 | 0.00 | — | 4,143 | — | ↗ |
| 2023-01-08 | Ricupati Agostino | Director | F-InKind | D | Common Stock | 151 | 345.17 | 52.1K | 2,028 | — | ↗ |
| 2023-01-08 | Andrews Brian G | Director | M-Exempt | D | Restricted Stock Units | 108 | 0.00 | — | 0 | — | ↗ |
| 2023-01-06 | Lindell Jody S | Director | M-Exempt | A | Common Stock | 1,000 | 128.35 | 128.4K | 14,543 | — | ↗ |
| 2022-12-19 | PETERSMEYER GARY S | Director | G-Gift | D | Common Stock | 125 | 0.00 | — | 2,909 | — | ↗ |
| 2022-12-13 | White Albert G III | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 51,226 | 329.83 | 16.90M | 51,226 | — | ↗ |
| 2022-12-13 | Warner Gerard H III | Director | A-Award | A | Restricted Stock Units | 2,653 | 0.00 | — | 2,653 | — | ↗ |
| 2022-12-13 | Sheffield Holly R | Director | A-Award | A | Restricted Stock Units | 1,592 | 0.00 | — | 1,592 | — | ↗ |
| 2022-12-13 | Ricupati Agostino | Director | A-Award | A | Restricted Stock Units | 2,122 | 0.00 | — | 2,122 | — | ↗ |
| 2022-12-13 | McBride Daniel G | Director / Officer | A-Award | A | Restricted Stock Units | 4,169 | 0.00 | — | 4,169 | — | ↗ |
| 2022-12-13 | Khadder Nicholas | Director | A-Award | A | Restricted Stock Units | 1,137 | 0.00 | — | 1,137 | — | ↗ |
| 2022-12-13 | Andrews Brian G | Officer | A-Award | A | Stock Options (Right to Buy) | 10,904 | 329.83 | 3.60M | 10,904 | — | ↗ |
| 2022-12-12 | PETERSMEYER GARY S | Director | M-Exempt | A | Common Stock | 1,000 | 154.77 | 154.8K | 3,034 | — | ↗ |
| 2022-10-31 | Lindell Jody S | Director | — | I | Common Stock | 0 | 0.00 | — | 6,250 | — | ↗ |
| 2022-10-01 | Lucchese Cynthia L | Director | A-Award | A | Restricted Stock Units | 512 | 0.00 | — | 512 | — | ↗ |
| 2022-09-01 | Khadder Nicholas | Director | A-Award | A | Stock Options (Right to Buy) | 3,159 | 0.00 | — | 3,159 | — | ↗ |
| 2022-08-08 | Khadder Nicholas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-01 | Ricupati Agostino | Officer | M-Exempt | A | Common Stock | 348 | 0.00 | — | 1,901 | — | ↗ |
| 2022-06-04 | Sheffield Holly R | Director | M-Exempt | A | Common Stock | 1,105 | 0.00 | — | 3,993 | — | ↗ |
| 2022-04-11 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 300 | 410.55 | 123.2K | 1,872 | — | ↗ |
| 2022-04-10 | PETERSMEYER GARY S | Director | G-Gift | A | Restricted Stock Units | 630 | 0.00 | — | 630 | — | ↗ |
| 2022-04-06 | Lindell Jody S | Director | G-Gift | D | Restricted Stock Units | 630 | 0.00 | — | 0 | — | ↗ |
| 2022-04-01 | WEISS ROBERT S | Director | M-Exempt | A | Common Stock | 770 | 0.00 | — | 71,759 | — | ↗ |
| 2022-04-01 | Rivas Maria | Director | M-Exempt | A | Common Stock | 502 | 0.00 | — | 502 | — | ↗ |
| 2022-04-01 | PETERSMEYER GARY S | Director | M-Exempt | D | Restricted Stock Units | 700 | 0.00 | — | 0 | — | ↗ |
| 2022-04-01 | MADDEN TERESA S | Director | A-Award | A | Restricted Stock Units | 630 | 0.00 | — | 630 | — | ↗ |
| 2022-04-01 | Lindell Jody S | Director | M-Exempt | A | Common Stock | 700 | 0.00 | — | 14,243 | — | ↗ |
| 2022-04-01 | KOZY WILLIAM A | Director | M-Exempt | A | Common Stock | 735 | 0.00 | — | 5,652 | — | ↗ |
| 2022-04-01 | Jay Colleen | Director | A-Award | A | Restricted Stock Units | 630 | 0.00 | — | 630 | — | ↗ |
| 2022-03-29 | WEISS ROBERT S | Director | S-Sale | D | Common Stock | 1,895 | 416.46 | 789.2K | 65,651 | — | ↗ |
| 2022-03-18 | Ricupati Agostino | Officer | M-Exempt | D | Stock Options (Right to Buy) | 3,248 | 229.66 | 745.9K | 0 | — | ↗ |
| 2022-02-01 | Warner Gerard H III | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,323 | — | ↗ |
| 2022-01-08 | Sheffield Holly R | Officer | M-Exempt | A | Common Stock | 589 | 0.00 | — | 3,073 | — | ↗ |
| 2022-01-08 | Ricupati Agostino | Officer | M-Exempt | D | Restricted Stock Units | 205 | 0.00 | — | 204 | — | ↗ |
| 2022-01-08 | Drury Mark J | Officer | M-Exempt | A | Common Stock | 228 | 0.00 | — | 2,169 | — | ↗ |
| 2022-01-08 | Andrews Brian G | Officer | F-InKind | D | Common Stock | 58 | 408.64 | 23.7K | 2,095 | — | ↗ |
| 2021-12-07 | White Albert G III | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 50,994 | 406.17 | 20.71M | 50,994 | — | ↗ |
| 2021-12-07 | Sheffield Holly R | Officer | A-Award | A | Stock Options (Right to Buy) | 10,474 | 406.17 | 4.25M | 10,474 | — | ↗ |
| 2021-12-07 | Ricupati Agostino | Officer | A-Award | A | Stock Options (Right to Buy) | 7,718 | 406.17 | 3.13M | 7,718 | — | ↗ |
| 2021-12-07 | McBride Daniel G | Officer | A-Award | A | Stock Options (Right to Buy) | 13,782 | 406.17 | 5.60M | 13,782 | — | ↗ |
| 2021-12-07 | Drury Mark J | Officer | A-Award | A | Restricted Stock Units | 1,108 | 0.00 | — | 1,108 | — | ↗ |
| 2021-12-07 | Andrews Brian G | Officer | A-Award | A | Stock Options (Right to Buy) | 10,199 | 406.17 | 4.14M | 10,199 | — | ↗ |
| 2021-09-19 | PETERSMEYER GARY S | Director | G-Gift | D | Stock Options (Right to buy) | 282 | 162.69 | 45.9K | 0 | — | ↗ |
| 2021-09-15 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 455 | 441.35 | 200.8K | 1,472 | — | ↗ |
| 2021-09-07 | McBride Daniel G | Officer | S-Sale | D | Common Stock | 5,642 | 453.63 | 2.56M | 32,115 | — | ↗ |
| 2021-09-07 | Andrews Brian G | Officer | M-Exempt | D | Stock Options (Right to Buy) | 2,567 | 162.28 | 416.6K | 0 | — | ↗ |
| 2021-07-12 | PETERSMEYER GARY S | Director | S-Sale | D | Common Stock | 400 | 412.28 | 164.9K | 1,927 | — | ↗ |
| 2021-07-02 | Lindell Jody S | Director | M-Exempt | A | Common Stock | 4,500 | 98.45 | 443.0K | 18,043 | — | ↗ |
| 2021-07-01 | Rivas Maria | Director | A-Award | A | Restricted Stock Units | 502 | 0.00 | — | 502 | — | ↗ |
| 2021-07-01 | Ricupati Agostino | Officer | M-Exempt | D | Restricted Stock Units | 348 | 0.00 | — | 348 | — | ↗ |
| 2021-06-17 | Ricupati Agostino | Officer | M-Exempt | D | Stock Options (Right to Buy) | 710 | 131.60 | 93.4K | 122 | — | ↗ |
| 2021-06-04 | Sheffield Holly R | Officer | M-Exempt | A | Common Stock | 1,105 | 0.00 | — | 2,774 | — | ↗ |
| 2021-04-16 | PETERSMEYER GARY S | Director | G-Gift | D | Restricted Stock Units | 700 | 0.00 | — | 0 | — | ↗ |
| 2021-04-15 | Ricupati Agostino | Officer | M-Exempt | D | Stock Options (Right to Buy) | 704 | 175.31 | 123.4K | 2,819 | — | ↗ |
| 2021-04-13 | Lindell Jody S | Director | G-Gift | A | Restricted Stock Units | 700 | 0.00 | — | 700 | — | ↗ |
| 2021-04-01 | WEISS ROBERT S | Director | A-Award | A | Restricted Stock Units | 770 | 0.00 | — | 770 | — | ↗ |
| 2021-04-01 | Ricupati Agostino | Officer | A-Award | A | Restricted Stock Units | 1,038 | 0.00 | — | 1,038 | — | ↗ |
| 2021-04-01 | PETERSMEYER GARY S | Director | M-Exempt | A | Common Stock | 989 | 0.00 | — | 2,327 | — | ↗ |
| 2021-04-01 | MADDEN TERESA S | Director | M-Exempt | D | Restricted Stock Units | 269 | 0.00 | — | 0 | — | ↗ |
| 2021-04-01 | Lindell Jody S | Director | A-Award | A | Restricted Stock Units | 700 | 0.00 | — | 700 | — | ↗ |
| 2021-04-01 | KOZY WILLIAM A | Director | M-Exempt | D | Restricted Stock Units | 989 | 0.00 | — | 0 | — | ↗ |
| 2021-04-01 | Jay Colleen | Director | M-Exempt | D | Restricted Stock Units | 989 | 0.00 | — | 0 | — | ↗ |
| 2021-03-08 | White Albert G III | Director / Officer | S-Sale | D | Common Stock | 16,371 | 389.45 | 6.38M | 55,159 | — | ↗ |
| 2021-02-01 | Auerbach Robert D | Officer | F-InKind | D | Common Stock | 290 | 365.11 | 105.9K | 2,759 | — | ↗ |
| 2021-01-08 | Sheffield Holly R | Officer | M-Exempt | A | Common Stock | 589 | 0.00 | — | 1,874 | — | ↗ |
| 2021-01-08 | Ricupati Agostino | Officer | M-Exempt | D | Restricted Stock Units | 255 | 0.00 | — | 765 | — | ↗ |
| 2021-01-08 | Drury Mark J | Officer | M-Exempt | A | Common Stock | 181 | 0.00 | — | 1,535 | — | ↗ |
| 2021-01-08 | Auerbach Robert D | Officer | F-InKind | D | Common Stock | 126 | 363.23 | 45.8K | 1,708 | — | ↗ |
| 2021-01-08 | Andrews Brian G | Officer | M-Exempt | A | Common Stock | 109 | 0.00 | — | 1,961 | — | ↗ |
| 2020-12-08 | White Albert G III | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 50,545 | 345.74 | 17.48M | 50,545 | — | ↗ |
| 2020-12-08 | Sheffield Holly R | Officer | A-Award | A | Stock Options (Right to Buy) | 10,406 | 345.74 | 3.60M | 10,406 | — | ↗ |
| 2020-12-08 | Ricupati Agostino | Officer | A-Award | A | Stock Options (Right to Buy) | 7,730 | 345.74 | 2.67M | 7,730 | — | ↗ |
| 2020-12-08 | McBride Daniel G | Officer | A-Award | A | Stock Options (Right to Buy) | 13,974 | 345.74 | 4.83M | 13,974 | — | ↗ |
| 2020-12-08 | Drury Mark J | Officer | A-Award | A | Restricted Stock Units | 1,157 | 0.00 | — | 1,157 | — | ↗ |
| 2020-12-08 | Andrews Brian G | Officer | A-Award | A | Restricted Stock Units | 1,446 | 0.00 | — | 1,881 | — | ↗ |
| 2020-12-01 | MADDEN TERESA S | Director | A-Award | A | Restricted Stock Units | 269 | 0.00 | — | 269 | — | ↗ |
| 2020-11-12 | MADDEN TERESA S | Director | — | D | Common Stock | 0 | 0.00 | — | 87 | — | ↗ |
| 2020-10-08 | Auerbach Robert D | Officer | S-Sale | D | Common Stock | 2,538 | 350.00 | 888.3K | 1,403 | — | ↗ |
| 2020-10-06 | PETERSMEYER GARY S | Director | M-Exempt | D | Non-employee Director (Stock Option (Right to Buy) | 1,000 | 162.69 | 162.7K | 1,782 | — | ↗ |
| 2020-09-16 | Lindell Jody S | Director | M-Exempt | D | Non-employee Director Stock Option (Right to Buy) | 6,500 | 66.80 | 434.2K | 0 | — | ↗ |
| 2020-09-11 | McBride Daniel G | Officer | G-Gift | D | Common Stock | 300 | 0.00 | — | 32,053 | — | ↗ |
| 2020-07-08 | White Albert G III | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 278.23 | 278.2K | 41,430 | — | ↗ |
| 2020-07-08 | Sheffield Holly R | Officer | P-Purchase | A | Common Stock | 534 | 280.20 | 149.6K | 1,414 | — | ↗ |
| 2020-07-01 | Ricupati Agostino | Officer | M-Exempt | A | Common Stock | 348 | 0.00 | — | 2,148 | — | ↗ |
| 2020-06-12 | Sheffield Holly R | Officer | P-Purchase | A | Common Stock | 880 | 283.18 | 249.2K | 880 | — | ↗ |
| 2020-06-11 | Ricupati Agostino | Officer | P-Purchase | A | Common Stock | 1,000 | 281.47 | 281.5K | 1,800 | — | ↗ |
| 2020-06-04 | Sheffield Holly R | Officer | M-Exempt | D | Restricted Stock Units | 1,105 | 0.00 | — | 3,314 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Albert G. White III President & Chief Executive Officer | 1.17M | — | 6.64M | 6.64M | 1.53M | 68.5K | 16.05M | 82.77% | ↗ |
| 2 | 2025 | Daniel G. McBride Executive Vice President, Chief Operating Officer, General Counsel & Secretary | 792.3K | — | 3.30M | — | 639.2K | 91.5K | 4.82M | 68.42% | ↗ |
| 3 | 2025 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 734.6K | — | 1.50M | 1.50M | 555.3K | 47.7K | 4.34M | 69.16% | ↗ |
| 4 | 2025 | Holly R. Sheffield President, CooperSurgical, Inc. | 646.2K | — | 2.50M | — | 435.5K | 75.0K | 3.66M | 68.37% | ↗ |
| 5 | 2025 | Gerard H. Warner III President, CooperVision, Inc. | 634.6K | — | 2.50M | — | 434.5K | 75.7K | 3.64M | 68.59% | ↗ |
| 6 | 2024 | Albert G. White III President & Chief Executive Officer | 1.13M | — | 12.48M | — | 1.70M | 117.9K | 15.43M | 80.89% | ↗ |
| 7 | 2024 | Daniel G. McBride Executive Vice President, Chief Operating Officer, General Counsel & Secretary | 759.6K | — | 3.10M | — | 721.4K | 184.1K | 4.76M | 65.05% | ↗ |
| 8 | 2024 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 759.6K | — | 3.10M | — | 721.4K | 184.1K | 4.76M | 65.05% | ↗ |
| 9 | 2024 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 650.0K | — | 2.40M | — | 588.6K | 88.6K | 3.73M | 64.39% | ↗ |
| 10 | 2024 | Holly R. Sheffield President, CooperSurgical, Inc. | 624.7K | — | 2.25M | — | 504.9K | 68.1K | 3.45M | 65.26% | ↗ |
| 11 | 2024 | Gerard H. Warner III President, CooperVision, Inc. | 548.7K | — | 2.00M | — | 475.2K | 105.0K | 3.13M | 63.92% | ↗ |
| 12 | 2023 | Albert G. White III President & Chief Executive Officer | 1.05M | — | 5.28M | 5.28M | 1.84M | 28.7K | 13.49M | 78.35% | ↗ |
| 13 | 2023 | Daniel G. McBride Executive Vice President, Chief Operating Officer, General Counsel & Secretary | 745.8K | — | 2.75M | — | 827.6K | 54.6K | 4.38M | 62.82% | ↗ |
| 14 | 2023 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 745.8K | — | 2.75M | — | 827.6K | 54.6K | 4.38M | 62.82% | ↗ |
| 15 | 2023 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 591.7K | — | 1.13M | 1.12M | 612.6K | 17.7K | 3.47M | 64.80% | ↗ |
| 16 | 2023 | Holly R. Sheffield President, CooperSurgical, Inc | 570.8K | — | 1.57M | 525.0K | 513.7K | 35.0K | 3.22M | 65.22% | ↗ |
| 17 | 2023 | Holly R. Sheffield President, CooperSurgical, Inc. | 570.8K | — | 1.57M | 525.0K | 513.7K | 35.0K | 3.22M | 65.22% | ↗ |
| 18 | 2023 | Gerard H. Warner III President, CooperVision, Inc. | 491.7K | — | 1.75M | — | 469.4K | 68.9K | 2.78M | 62.95% | ↗ |
| 19 | 2022 | Albert G. White III President & Chief Executive Officer | 925.0K | — | 4.63M | 4.63M | 1.54M | 16.0K | 11.74M | 78.82% | ↗ |
| 20 | 2022 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 720.9K | — | 1.25M | 1.25M | 796.4K | 16.0K | 4.03M | 61.99% | ↗ |
| 21 | 2022 | Holly R. Sheffield President, CooperSurgical, Inc. | 545.9K | — | 950.0K | 950.0K | 468.8K | 15.9K | 2.93M | 64.84% | ↗ |
| 22 | 2022 | Holly R. Sheffield President, CooperSurgical, Inc | 545.9K | — | 950.0K | 950.0K | 468.8K | 15.9K | 2.93M | 64.84% | ↗ |
| 23 | 2022 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 541.7K | — | 924.8K | 925.0K | 506.6K | 16.0K | 2.91M | 63.48% | ↗ |
| 24 | 2022 | Gerard H. Warner III President, CooperVision, Inc. | 437.7K | — | 875.3K | 875.0K | 391.6K | 32.5K | 2.61M | 67.01% | ↗ |
| 25 | 2021 | Albert G. White III President & Chief Executive Officer | 925.0K | 375.8K | 4.25M | 4.25M | 1.13M | 67.1K | 10.99M | 77.31% | ↗ |
| 26 | 2021 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 700.0K | 182.0K | 1.18M | 1.17M | 546.0K | 75.6K | 3.85M | 60.98% | ↗ |
| 27 | 2021 | Holly R. Sheffield President, CooperSurgical, Inc | 525.0K | 119.4K | 875.1K | 874.9K | 358.3K | 55.9K | 2.81M | 62.31% | ↗ |
| 28 | 2021 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 500.0K | 113.8K | 824.9K | 825.0K | 341.3K | 55.5K | 2.66M | 62.02% | ↗ |
| 29 | 2021 | Agostino Ricupati Chief Accounting Officer / Senior Vice President, Finance & Tax | 381.8K | 68.2K | 400.1K | 649.9K | 204.7K | 62.9K | 1.77M | 59.40% | ↗ |
| 30 | 2020 | Albert G. White III President & Chief Executive Officer | 925.0K | 867.2K | — | 7.70M | — | 91.8K | 9.58M | 80.34% | ↗ |
| 31 | 2020 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 700.0K | 420.0K | — | 2.16M | — | 97.3K | 3.38M | 63.96% | ↗ |
| 32 | 2020 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 700.0K | 420.0K | — | 2.16M | — | 97.3K | 3.38M | 63.96% | ↗ |
| 33 | 2020 | Holly R. Sheffield President, CooperSurgical, Inc | 525.0K | 255.9K | — | 1.69M | — | 71.8K | 2.55M | 66.52% | ↗ |
| 34 | 2020 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 500.0K | 243.8K | — | 1.48M | — | 80.0K | 2.30M | 64.17% | ↗ |
| 35 | 2020 | Robert D. Auerbach, M.D. Special Advisor to the CEO | 475.0K | 231.6K | 1.15M | — | — | 92.9K | 1.95M | 58.99% | ↗ |
| 36 | 2019 | Albert G. White, III President & Chief Executive Officer | 925.0K | 288.6K | — | 5.50M | 865.8K | 145.5K | 7.72M | 71.20% | ↗ |
| 37 | 2019 | Albert G. White III President & Chief Executive Officer | 925.0K | 288.6K | — | 5.50M | 865.8K | 145.5K | 7.72M | 71.20% | ↗ |
| 38 | 2019 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 700.0K | 175.3K | — | 2.00M | 525.8K | 180.2K | 3.58M | 55.84% | ↗ |
| 39 | 2019 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 700.0K | 175.3K | — | 2.00M | 525.8K | 180.2K | 3.58M | 55.84% | ↗ |
| 40 | 2019 | Holly R. Sheffield Executive Vice President & Chief Strategy Officer | 525.0K | 106.5K | 750.0K | 750.0K | 319.4K | 54.7K | 2.51M | 59.87% | ↗ |
| 41 | 2019 | Holly R. Sheffield President, CooperSurgical, Inc | 525.0K | 106.5K | 750.0K | 750.0K | 319.4K | 54.7K | 2.51M | 59.87% | ↗ |
| 42 | 2019 | Brian G. Andrews Senior Vice President, Chief Financial Officer & Treasurer | 425.0K | 86.2K | — | 1.10M | 258.6K | 121.6K | 1.99M | 55.24% | ↗ |
| 43 | 2019 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 425.0K | 86.2K | — | 1.10M | 258.6K | 121.6K | 1.99M | 55.24% | ↗ |
| 44 | 2019 | Robert D. Auerbach, M.D. President, CooperSurgical, Inc | 425.0K | 72.7K | 500.1K | 500.0K | 218.2K | 145.3K | 1.86M | 53.73% | ↗ |
| 45 | 2019 | Robert D. Auerbach, M.D. Special Advisor to the CEO | 425.0K | 72.7K | 500.1K | 500.0K | 218.2K | 145.3K | 1.86M | 53.73% | ↗ |
| 46 | 2018 | Robert S. Weiss President & Chief Executive Officer (Former) | 925.0K | 235.0K | 937.2K | 3.49M | 704.9K | 102.6K | 6.40M | 69.25% | ↗ |
| 47 | 2018 | Albert G. White, III President & Chief Executive Officer | 688.5K | 165.4K | 432.9K | 4.27M | 496.3K | 18.8K | 6.07M | 77.44% | ↗ |
| 48 | 2018 | Albert G. White III President & Chief Executive Officer | 688.5K | 165.4K | 432.9K | 4.27M | 496.3K | 18.8K | 6.07M | 77.44% | ↗ |
| 49 | 2018 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 613.5K | 122.2K | 432.9K | 2.27M | 366.6K | 30.9K | 3.83M | 70.42% | ↗ |
| 50 | 2018 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 613.5K | 122.2K | 432.9K | 2.27M | 366.6K | 30.9K | 3.83M | 70.42% | ↗ |
| 51 | 2018 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer (Former) | 482.0K | 181.9K | 379.2K | 956.7K | 111.9K | 763.3K | 2.88M | 46.46% | ↗ |
| 52 | 2018 | Holly R. Sheffield President, CooperSurgical, Inc | 207.4K | 31.6K | 1.00M | 1,000.0K | 94.8K | 255.6K | 2.59M | 77.24% | ↗ |
| 53 | 2018 | Holly R. Sheffield Executive Vice President & Chief Strategy Officer | 207.4K | 31.6K | 1.00M | 1,000.0K | 94.8K | 255.6K | 2.59M | 77.24% | ↗ |
| 54 | 2018 | Robert D. Auerbach, M.D. President, CooperSurgical, Inc | 380.0K | 57.7K | 486.0K | 350.0K | 173.1K | 20.2K | 1.47M | 56.99% | ↗ |
| 55 | 2018 | Robert D. Auerbach, M.D. Special Advisor to the CEO | 380.0K | 57.7K | 486.0K | 350.0K | 173.1K | 20.2K | 1.47M | 56.99% | ↗ |
| 56 | 2018 | Robert D. Auerbach, M.D. Pr esident, CooperSurgical, Inc | 380.0K | 57.7K | 486.0K | 350.0K | 173.1K | 20.2K | 1.47M | 56.99% | ↗ |
| 57 | 2018 | Brian G. Andrews Senior Vice President, Chief Financial Officer & Treasurer | 328.7K | 37.6K | 124.9K | 578.0K | 112.7K | 15.6K | 1.20M | 58.70% | ↗ |
| 58 | 2018 | Brian G. Andrews Executive Vice President, Chief Financial Officer & Treasurer | 328.7K | 37.6K | 124.9K | 578.0K | 112.7K | 15.6K | 1.20M | 58.70% | ↗ |
| 59 | 2017 | Robert S. Weiss President & Chief Executive Officer | 925.0K | 284.7K | 937.1K | 3.49M | 854.0K | 64.1K | 6.56M | 67.55% | ↗ |
| 60 | 2017 | Robert S. Weiss President & Chief Executive Officer (Former) | 925.0K | 284.7K | 937.1K | 3.49M | 854.0K | 64.1K | 6.56M | 67.55% | ↗ |
| 61 | 2017 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 525.0K | 112.9K | 432.9K | 1.26M | 338.7K | 67.2K | 2.74M | 61.93% | ↗ |
| 62 | 2017 | Daniel G. McBride Executive Vice President & Chief Operating Officer | 525.0K | 112.9K | 432.9K | 1.26M | 338.7K | 67.2K | 2.74M | 61.93% | ↗ |
| 63 | 2017 | Albert G. White III President & Chief Executive Officer | 525.0K | 98.7K | 432.9K | 1.26M | 296.0K | 43.7K | 2.66M | 63.80% | ↗ |
| 64 | 2017 | Albert G. White, III President & Chief Executive Officer | 525.0K | 98.7K | 432.9K | 1.26M | 296.0K | 43.7K | 2.66M | 63.80% | ↗ |
| 65 | 2017 | Albert G. White III Executive Vice President & Chief Strategy Officer / Chief Executive Officer, Cooper Medical, Inc. | 525.0K | 98.7K | 432.9K | 1.26M | 296.0K | 43.7K | 2.66M | 63.80% | ↗ |
| 66 | 2017 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer (Former) | 468.0K | 86.4K | 379.2K | 956.6K | 259.2K | 83.3K | 2.23M | 59.83% | ↗ |
| 67 | 2017 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 468.0K | 86.4K | 379.2K | 956.6K | 259.2K | 83.3K | 2.23M | 59.83% | ↗ |
| 68 | 2017 | Agostino Ricupati Senior Vice President, Finance and Tax & Chief Accounting Officer | 327.2K | 45.3K | 508.0K | 155.0K | 135.9K | 42.9K | 1.21M | 54.60% | ↗ |
| 69 | 2016 | Robert S. Weiss President & Chief Executive Officer | 875.0K | 279.3K | 937.1K | 3.49M | 838.0K | 86.9K | 6.51M | 68.05% | ↗ |
| 70 | 2016 | Robert S. Weiss President & Chief Executive Officer (Former) | 875.0K | 279.3K | 937.1K | 3.49M | 838.0K | 86.9K | 6.51M | 68.05% | ↗ |
| 71 | 2016 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 495.0K | 108.7K | 432.9K | 2.26M | 326.0K | 84.3K | 3.71M | 72.68% | ↗ |
| 72 | 2016 | Daniel G. McBride, Esq. Executive Vice President & Chief Operating Officer/ President of CooperVision, Inc. | 495.0K | 108.7K | 432.9K | 2.26M | 326.0K | 84.3K | 3.71M | 72.68% | ↗ |
| 73 | 2016 | Albert G. White III Executive Vice President & Chief Strategy Officer/ Chief Executive Officer of Cooper Medical, Inc. | 475.0K | 111.0K | 432.9K | 2.00M | 332.9K | 67.2K | 3.42M | 71.16% | ↗ |
| 74 | 2016 | Albert G. White III Executive Vice President & Chief Strategy Officer / Chief Executive Officer, Cooper Medical, Inc. | 475.0K | 111.0K | 432.9K | 2.00M | 332.9K | 67.2K | 3.42M | 71.16% | ↗ |
| 75 | 2016 | Albert G. White III President & Chief Executive Officer | 475.0K | 111.0K | 432.9K | 2.00M | 332.9K | 67.2K | 3.42M | 71.16% | ↗ |
| 76 | 2016 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer (Former) | 454.0K | 87.0K | 379.2K | 956.6K | 260.9K | 94.6K | 2.23M | 59.84% | ↗ |
| 77 | 2016 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 454.0K | 87.0K | 379.2K | 956.6K | 260.9K | 94.6K | 2.23M | 59.84% | ↗ |
| 78 | 2016 | Greg W. Matz Senior Vice President, Chief Financial Officer & Chief Risk Officer | 425.0K | 74.6K | 302.6K | 807.4K | 223.9K | 63.4K | 1.90M | 58.52% | ↗ |
| 79 | 2015 | Robert S. Weiss President & Chief Executive Officer | 875.0K | 218.8K | 851.9K | 3.17M | 470.8K | 155.0K | 5.75M | 70.08% | ↗ |
| 80 | 2015 | Daniel G. McBride Executive Vice President & Chief Operating Officer / President, CooperVision, Inc. | 495.0K | 86.6K | 968.6K | 575.0K | 186.8K | 99.2K | 2.41M | 64.02% | ↗ |
| 81 | 2015 | Daniel G. McBride, Esq. Executive Vice President & Chief Operating Officer/ President of CooperVision, Inc. | 495.0K | 86.6K | 968.6K | 575.0K | 186.8K | 99.2K | 2.41M | 64.02% | ↗ |
| 82 | 2015 | Daniel G. McBride Executive Vice President & Chief Operating Officer President, CooperVision | 495.0K | 86.6K | 968.6K | 575.0K | 186.8K | 99.2K | 2.41M | 64.02% | ↗ |
| 83 | 2015 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 454.0K | 68.1K | 779.6K | 434.8K | 146.6K | 134.6K | 2.02M | 60.19% | ↗ |
| 84 | 2015 | Greg W. Matz Senior Vice President, Chief Financial Officer & Chief Risk Officer | 425.0K | 58.4K | 642.2K | 367.1K | 125.8K | 56.9K | 1.68M | 60.24% | ↗ |
| 85 | 2015 | Albert G. White, III Executive Vice President & Chief Strategy Officer | 425.0K | 58.4K | 642.2K | 367.1K | 125.8K | 56.0K | 1.67M | 60.27% | ↗ |
| 86 | 2015 | Albert G. White III Executive Vice President & Chief Strategy Officer / Chief Executive Officer, Cooper Medical, Inc. | 425.0K | 58.4K | 642.2K | 367.1K | 125.8K | 56.0K | 1.67M | 60.27% | ↗ |
| 87 | 2015 | Albert G. White III Executive Vice President & Chief Strategy Officer/ Chief Executive Officer of Cooper Medical, Inc. | 425.0K | 58.4K | 642.2K | 367.1K | 125.8K | 56.0K | 1.67M | 60.27% | ↗ |
| 88 | 2014 | Robert S. Weiss President & Chief Executive Officer | 840.0K | 252.0K | 851.9K | 3.05M | 655.2K | 67.8K | 5.72M | 68.27% | ↗ |
| 89 | 2014 | Daniel G. McBride, Esq. Executive Vice President & Chief Operating Officer/ President of CooperVision, Inc. | 450.0K | 94.5K | 882.0K | 500.0K | 245.7K | 56.5K | 2.23M | 62.01% | ↗ |
| 90 | 2014 | Daniel G. McBride Executive Vice President & Chief Operating Officer; President, CooperVision, Inc. | 450.0K | 94.5K | 882.0K | 500.0K | 245.7K | 56.5K | 2.23M | 62.01% | ↗ |
| 91 | 2014 | Daniel G. McBride Executive Vice President & Chief Operating Officer President, CooperVision | 450.0K | 94.5K | 882.0K | 500.0K | 245.7K | 56.5K | 2.23M | 62.01% | ↗ |
| 92 | 2014 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 440.6K | 79.3K | 779.5K | 434.8K | 206.2K | 108.0K | 2.05M | 59.28% | ↗ |
| 93 | 2014 | Albert G. White III Executive Vice President & Chief Strategy Officer/ Chief Executive Officer of Cooper Medical, Inc. | 386.1K | 113.6K | 608.8K | 342.0K | 165.7K | 50.3K | 1.67M | 57.05% | ↗ |
| 94 | 2014 | Albert G. White, III Executive Vice President & Chief Strategy Officer | 386.1K | 113.6K | 608.8K | 342.0K | 165.7K | 50.3K | 1.67M | 57.05% | ↗ |
| 95 | 2014 | Albert G. White, III Senior Vice President & Chief Strategy Officer | 386.1K | 113.6K | 608.8K | 342.0K | 165.7K | 50.3K | 1.67M | 57.05% | ↗ |
| 96 | 2014 | Greg W. Matz Senior Vice President, Chief Financial Officer & Chief Risk Officer | 386.1K | 63.7K | 608.8K | 342.0K | 165.7K | 48.9K | 1.62M | 58.87% | ↗ |
| 97 | 2013 | Robert S. Weiss President & Chief Executive Officer | 800.0K | 200.0K | 1.08M | 2.90M | 787.2K | 59.1K | 5.78M | 68.92% | ↗ |
| 98 | 2013 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 419.7K | 62.9K | 906.9K | 422.1K | 247.8K | 72.0K | 2.13M | 62.36% | ↗ |
| 99 | 2013 | John A. Weber President, CooperVision [Former] | 419.7K | 62.9K | 906.9K | 422.1K | 228.1K | 68.3K | 2.10M | 63.15% | ↗ |
| 100 | 2013 | Daniel G. McBride Executive Vice President & Chief Operating Officer; President, CooperVision, Inc. | 367.7K | 101.1K | 681.2K | 325.7K | 199.0K | 16.4K | 1.69M | 59.73% | ↗ |
| 101 | 2013 | Daniel G. McBride, Esq. Executive Vice President & Chief Operating Officer President, CooperVision, Inc. | 367.7K | 101.1K | 681.2K | 325.7K | 199.0K | 16.4K | 1.69M | 59.73% | ↗ |
| 102 | 2013 | Daniel G. McBride Executive Vice President & Chief Operating Officer President, CooperVision | 367.7K | 101.1K | 681.2K | 325.7K | 199.0K | 16.4K | 1.69M | 59.73% | ↗ |
| 103 | 2013 | Greg W. Matz Senior Vice President, Chief Financial Officer & Chief Risk Officer | 367.7K | 50.6K | 681.2K | 325.7K | 199.0K | 18.1K | 1.64M | 61.31% | ↗ |
| 104 | 2013 | Greg W. Matz Vice President, Chief Financial Officer & Chief Risk Officer | 367.7K | 50.6K | 681.2K | 325.7K | 199.0K | 18.1K | 1.64M | 61.31% | ↗ |
| 105 | 2013 | Albert G. White, III Senior Vice President & Chief Strategy Officer | 367.7K | 50.6K | 681.2K | 325.7K | 199.0K | 14.9K | 1.63M | 61.63% | ↗ |
| 106 | 2013 | Albert G. White, III Executive Vice President & Chief Strategy Officer | 367.7K | 50.6K | 681.2K | 325.7K | 199.0K | 14.9K | 1.63M | 61.63% | ↗ |
| 107 | 2012 | Robert S. Weiss President & Chief Executive Officer | 765.0K | 286.9K | 989.4K | 2.42M | 805.5K | 149.6K | 5.42M | 62.95% | ↗ |
| 108 | 2012 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 403.5K | 90.8K | 1.15M | — | 254.9K | 154.8K | 2.05M | 55.96% | ↗ |
| 109 | 2012 | John A. Weber President, CooperVision [Former] | 403.5K | 90.8K | 1.15M | — | 224.7K | 89.9K | 1.96M | 58.68% | ↗ |
| 110 | 2012 | Carol R. Kaufman Executive Vice President, Secretary & Chief Administrative Officer | 403.5K | 90.8K | 1.15M | — | 254.9K | 154.8K | 1.94M | 59.32% | ↗ |
| 111 | 2012 | John A. Weber President, CooperVision | 403.5K | 90.8K | 1.15M | — | 224.7K | 89.9K | 1.91M | 60.25% | ↗ |
| 112 | 2012 | Albert G. White, III Senior Vice President & Chief Strategy Officer | 353.6K | 72.9K | 847.7K | — | 204.8K | 54.9K | 1.53M | 55.27% | ↗ |
| 113 | 2012 | Greg W. Matz Vice President, Chief Financial Officer & Chief Risk Officer | 353.6K | 72.9K | 847.7K | — | 204.8K | 48.4K | 1.53M | 55.50% | ↗ |
| 114 | 2012 | Greg W. Matz Senior Vice President, Chief Financial Officer & Chief Risk Officer | 353.6K | 72.9K | 847.7K | — | 204.8K | 48.4K | 1.53M | 55.50% | ↗ |
| 115 | 2012 | Albert G. White III Vice President & Chief Strategic Officer | 353.6K | 72.9K | 847.7K | — | 204.8K | 54.9K | 1.50M | 56.65% | ↗ |
| 116 | 2012 | Greg W. Matz Vice President & Chief Financial Officer | 353.6K | 72.9K | 847.7K | — | 204.8K | 48.4K | 1.49M | 56.80% | ↗ |
| 117 | 2012 | Eugene J. Midlock Vice President, Tax | 269.5K | 46.8K | 573.9K | — | 131.6K | 68.9K | 1.04M | 55.06% | ↗ |
| 118 | 2011 | Robert S. Weiss President & Chief Executive Officer | 735.0K | 147.0K | 871.1K | 2.23M | 907.4K | 144.5K | 5.03M | 61.58% | ↗ |
| 119 | 2011 | Eugene J. Midlock Vice President, Tax | 406.0K | 48.7K | 1.10M | — | 300.7K | 51.9K | 1.87M | 58.61% | ↗ |
| 120 | 2011 | Eugene J. Midlock Senior Vice President & Chief Financial Officer | 406.0K | 48.7K | 1.10M | — | 300.7K | 51.9K | 1.87M | 58.61% | ↗ |
| 121 | 2011 | John A. Weber President, CooperVision [Former] | 388.0K | 34.9K | 1.10M | — | 250.5K | 57.3K | 1.83M | 59.99% | ↗ |
| 122 | 2011 | John A. Weber President, CooperVision | 388.0K | 34.9K | 1.10M | — | 250.5K | 57.3K | 1.80M | 60.91% | ↗ |
| 123 | 2011 | Carol R. Kaufman Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer | 378.2K | 42.7K | 908.0K | — | 263.8K | 98.4K | 1.69M | 53.69% | ↗ |
| 124 | 2011 | Carol R. Kaufman Executive Vice President, Secretary & Chief Administrative Officer | 378.2K | 42.7K | 908.0K | — | 263.8K | 98.4K | 1.61M | 56.35% | ↗ |
| 125 | 2011 | Nicholas J. Pichotta Chief Executive Officer, CooperSurgical | 317.0K | 35.7K | 803.4K | — | 185.0K | 58.6K | 1.36M | 59.16% | ↗ |
| 126 | 2011 | Greg W. Matz Vice President, Chief Financial Officer & Chief Risk Officer | 286.9K | 135.8K | 748.2K | — | 138.8K | 23.7K | 1.33M | 56.11% | ↗ |
| 127 | 2011 | Greg W. Matz Vice President & Chief Financial Officer | 286.9K | 135.8K | 748.2K | — | 138.8K | 23.7K | 1.32M | 56.65% | ↗ |
| 128 | 2010 | Robert S. Weiss President & Chief Executive Officer | 700.0K | 315.0K | 182.7K | — | 913.5K | 93.2K | 2.13M | 8.59% | ↗ |
| 129 | 2010 | Greg W. Matz Vice President & Chief Financial Officer | 137.5K | 23.5K | — | 691.7K | 70.4K | 6.3K | 929.4K | 74.42% | ↗ |
| 130 | 2010 | Gregory W. Matz Vice President & Chief Financial Officer, CooperVision | 137.5K | — | — | 691.7K | 93.9K | 6.3K | 929.4K | 74.42% | ↗ |
| 131 | 2010 | Eugene J. Midlock Senior Vice President & Chief Financial Officer | 390.0K | 105.3K | 82.2K | — | 305.4K | 47.2K | 901.6K | 9.12% | ↗ |
| 132 | 2010 | Eugene J. Midlock Vice President, Tax | 390.0K | 105.3K | 82.2K | — | 305.4K | 47.2K | 901.6K | 9.12% | ↗ |
| 133 | 2010 | Robert D. Auerbach, M.D. Senior Vice President & Chief Medical Officer, CooperSurgical | 240.0K | — | 237.5K | 216.6K | 166.2K | 26.2K | 869.4K | 52.23% | ↗ |
| 134 | 2010 | Carol R. Kaufman Senior Vice President, Legal Affairs, Secretary & Chief Administrative Officer | 360.0K | — | 82.2K | — | 347.5K | 70.4K | 808.0K | 10.17% | ↗ |
| 135 | 2010 | Carol R. Kaufman Executive Vice President, Secretary & Chief Administrative Officer | 360.0K | 89.1K | 82.2K | — | 258.4K | 70.4K | 808.0K | 10.17% | ↗ |
| 136 | 2010 | J ohn A. Weber President, CooperVision | 370.0K | — | 82.2K | — | 337.0K | 27.9K | 801.2K | 10.26% | ↗ |
| 137 | 2010 | John A. Weber President, CooperVision | 370.0K | 99.9K | 82.2K | — | 237.1K | 27.9K | 801.2K | 10.26% | ↗ |
| 138 | 2010 | Rodney E. Folden Vice President & Corporate Controller | 248.0K | — | 169.9K | 144.4K | 174.1K | 65.5K | 749.1K | 41.96% | ↗ |
| 139 | 2010 | Nicholas J. Pichotta Chief Executive Officer, CooperSurgical | 305.0K | 60.1K | 60.3K | — | 177.5K | 45.5K | 623.3K | 9.67% | ↗ |
| 140 | 2009 | Robert S. Weiss President & Chief Executive Officer | 600.0K | 150.0K | 93.9K | 553.4K | 108.0K | 129.6K | 1.52M | 42.50% | ↗ |
| 141 | 2009 | Paul L. Remmell President & Chief Operating Officer of CooperSurgical | 295.0K | — | 106.8K | 503.8K | 199.1K | 62.0K | 1.12M | 54.76% | ↗ |
| 142 | 2009 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical | 300.0K | — | 8.4K | 503.8K | 209.3K | 125.1K | 1.07M | 47.79% | ↗ |
| 143 | 2009 | Nicholas J. Pichotta Chief Executive Officer, CooperSurgical | 300.0K | 27.0K | 8.4K | 503.8K | 182.3K | 125.1K | 1.04M | 49.03% | ↗ |
| 144 | 2009 | Eugene J. Midlock Senior Vice President & Chief Financial Officer | 380.0K | 57.0K | 42.3K | 318.4K | 41.0K | 58.3K | 859.2K | 41.97% | ↗ |
| 145 | 2009 | J ohn A. Weber President, CooperVision | 360.0K | — | 42.3K | 318.4K | 92.9K | 31.3K | 826.8K | 43.62% | ↗ |
| 146 | 2009 | John A. Weber President, CooperVision | 360.0K | 54.0K | 42.3K | 318.4K | 38.9K | 31.3K | 826.8K | 43.62% | ↗ |
| 147 | 2009 | Carol R. Kaufman Executive Vice President, Secretary & Chief Administrative Officer | 350.0K | 43.8K | 31.0K | 233.5K | 31.5K | 92.0K | 708.4K | 37.33% | ↗ |
| 148 | 2009 | Carol R. Kaufman Senior Vice President, Legal Affairs, Secretary & Chief Administrative Officer | 350.0K | — | 31.0K | 233.5K | 75.3K | 92.0K | 708.4K | 37.33% | ↗ |
| 149 | 2008 | John A. Weber President, CooperVision | 355.2K | — | — | 652.1K | 83.7K | 13.2K | 1.10M | 59.33% | ↗ |
| 150 | 2008 | Carol R. Kaufman Senior Vice President of Legal Affairs, Secretary & Chief Administrative Officer | 350.0K | — | — | 646.2K | 64.8K | 31.7K | 1.08M | 59.80% | ↗ |
| 151 | 2008 | Paul L. Remmell President & Chief Operating Officer of CooperSurgical | 295.0K | — | 61.5K | 498.6K | 170.6K | 9.4K | 1.03M | 54.12% | ↗ |
| 152 | 2008 | Robert S. Weiss President & Chief Executive Officer | 600.0K | — | — | 192.7K | 222.0K | 37.4K | 1.03M | 18.63% | ↗ |
| 153 | 2008 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical | 300.0K | — | — | 498.6K | 176.9K | 80.5K | 1.03M | 48.58% | ↗ |
| 154 | 2008 | Eugene J. Midlock Senior Vice President & Chief Financial Officer | 371.7K | — | — | 300.5K | 78.9K | 47.1K | 772.8K | 38.88% | ↗ |
| 155 | 2008 | J ohn A. Weber President, CooperVision | 355.2K | — | — | 247.3K | 83.7K | 13.2K | 694.3K | 35.62% | ↗ |
| 156 | 2008 | Carol R. Kaufman Senior Vice President, Legal Affairs, Secretary & Chief Administrative Officer | 350.0K | — | — | 96.4K | 64.8K | 31.7K | 530.7K | 18.16% | ↗ |
| 157 | 2008 | Steven M. Neil Former Executive Vice President & Chief Financial Officer | 58.4K | — | — | — | — | 8.1K | 66.4K | 0.00% | ↗ |
| 158 | 2007 | Robert S. Weiss Executive Vice President & Chief Operating Officer, and President of CooperVision, Inc. | 475.0K | — | — | 951.1K | 103.8K | 48.3K | 1.54M | 61.57% | ↗ |
| 159 | 2007 | Robert S. Weiss President & Chief Executive Officer | 475.0K | — | — | 906.0K | 103.8K | 48.3K | 1.50M | 60.42% | ↗ |
| 160 | 2007 | Steven M. Neil Executive Vice President & Chief Financial Officer | 380.0K | 25.0K | — | 648.5K | 121.2K | 27.9K | 1.19M | 54.56% | ↗ |
| 161 | 2007 | Steven M. Neil Former Executive Vice President & Chief Financial Officer | 380.0K | 25.0K | — | 581.8K | 121.2K | 27.9K | 1.12M | 51.86% | ↗ |
| 162 | 2007 | Eugene J. Midlock Vice President, Finance | 329.3K | — | — | 396.3K | 93.5K | 198.3K | 992.7K | 39.92% | ↗ |
| 163 | 2007 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 285.0K | — | — | 475.5K | 181.3K | 83.7K | 987.5K | 48.15% | ↗ |
| 164 | 2007 | A. Thomas Bender President & Chief Executive Officer | 750.0K | — | — | — | 189.2K | 30.6K | 958.8K | 0.00% | ↗ |
| 165 | 2007 | Eugene J. Midlock Senior Vice President & Chief Financial Officer | 329.3K | — | — | 315.8K | 93.5K | 198.3K | 912.3K | 34.62% | ↗ |
| 166 | 2007 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical | 285.0K | — | — | 389.6K | 181.3K | 83.7K | 901.6K | 43.21% | ↗ |
| 167 | 2006 | A. Thomas Bender President & Chief Executive Officer | 725.0K | 95.2K | — | 66.0K | — | 10.4K | 896.6K | 7.36% | ↗ |
| 168 | 2006 | Robert S. Weiss Executive Vice- President & Chief Operating Officer | 462.5K | 52.6K | — | 54.0K | — | 5.3K | 574.4K | 9.40% | ↗ |
| 169 | 2006 | Gregory A. Fryling President & Chief Operating Officer of CooperVision, Inc. | 425.0K | 38.7K | — | 49.5K | — | 3.1K | 516.2K | 9.59% | ↗ |
| 170 | 2006 | Steven M. Neil Vice-President & Chief Financial Officer | 367.5K | 75.8K | — | 40.0K | — | 2.9K | 486.2K | 8.23% | ↗ |
| 171 | 2006 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 275.0K | 136.4K | — | 25.0K | — | 39.8K | 476.2K | 5.25% | ↗ |
| 172 | 2005 | A. Thomas Bender President & Chief Executive Officer | 600.0K | 99.0K | — | 66.0K | — | 8.6K | 773.6K | 8.53% | ↗ |
| 173 | 2005 | Gregory A. Fryling President & Chief Operating Officer of CooperVision, Inc. | 339.6K | 108.5K | — | 94.0K | — | 2.8K | 544.9K | 17.25% | ↗ |
| 174 | 2005 | Robert S. Weiss Executive Vice President & Chief Operating Officer | 400.0K | 60.0K | — | 54.0K | — | 11.0K | 525.0K | 10.28% | ↗ |
| 175 | 2005 | Robert S. Weiss Executive Vice- President & Chief Operating Officer | 400.0K | 60.0K | — | 54.0K | — | 3.8K | 517.8K | 10.43% | ↗ |
| 176 | 2005 | Steven M. Neil Vice President, Chief Financial Officer & Acting Treasurer | 269.4K | 86.1K | — | 70.0K | — | 8.8K | 434.3K | 16.12% | ↗ |
| 177 | 2005 | Steven M. Neil Vice-President & Chief Financial Officer | 269.4K | 86.1K | — | 70.0K | — | 2.8K | 428.3K | 16.35% | ↗ |
| 178 | 2005 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 257.0K | 97.7K | — | 25.0K | — | 39.7K | 419.3K | 5.96% | ↗ |
| 179 | 2005 | Carol R. Kaufman Sr. Vice President of Legal Affairs, Secretary & Chief Administrative Officer | 270.0K | 86.3K | — | 35.5K | — | 10.4K | 402.1K | 8.83% | ↗ |
| 180 | 2004 | A. Thomas Bender President & Chief Executive Officer | 500.0K | 434.5K | — | 66.0K | — | 7.1K | 1.01M | 6.55% | ↗ |
| 181 | 2004 | Robert S. Weiss Executive Vice President & Chief Operating Officer | 341.0K | 269.4K | — | 54.0K | — | 10.2K | 674.5K | 8.01% | ↗ |
| 182 | 2004 | Robert S. Weiss Executive Vice- President & Chief Operating Officer | 341.0K | 269.4K | — | 54.0K | — | 3.0K | 667.3K | 8.09% | ↗ |
| 183 | 2004 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 245.0K | 147.0K | — | 20.0K | — | 39.0K | 451.0K | 4.43% | ↗ |
| 184 | 2004 | Carol R. Kaufman Sr. Vice President of Legal Affairs, Secretary & Chief Administrative Officer | 236.0K | 167.8K | — | 35.5K | — | 9.6K | 448.9K | 7.91% | ↗ |
| 185 | 2004 | Gregory A. Fryling President & Chief Operating Officer of CooperVision, Inc. | 275.0K | 63.3K | — | — | — | 2.0K | 340.3K | 0.00% | ↗ |
| 186 | 2003 | A. Thomas Bender President & Chief Executive Officer | 461.3K | 393.3K | — | 166.0K | — | 10.5K | 1.03M | 16.10% | ↗ |
| 187 | 2003 | A. Thomas Bender President and Chief Executive Officer | 461.3K | 393.3K | — | 166.0K | — | 3.3K | 1.02M | 16.21% | ↗ |
| 188 | 2003 | Robert S. Weiss Executive Vice President & Chief Operating Officer | 324.7K | 251.6K | — | 54.0K | — | 9.8K | 640.2K | 8.44% | ↗ |
| 189 | 2003 | Robert S. Weiss Executive Vice President and Chief Financial Officer | 324.7K | 251.6K | — | 54.0K | — | 2.6K | 633.0K | 8.53% | ↗ |
| 190 | 2003 | Gregory A. Fryling President & Chief Operating Officer of CooperVision, Inc. | 244.0K | 177.9K | — | 159.0K | — | 7.6K | 588.4K | 27.02% | ↗ |
| 191 | 2003 | Gregory A. Fryling Chief Operating Officer of CooperVision, Inc. | 244.0K | 177.9K | — | 159.0K | — | 1.6K | 582.4K | 27.30% | ↗ |
| 192 | 2003 | Carol R. Kaufman Sr. Vice President of Legal Affairs, Secretary & Chief Administrative Officer | 225.0K | 156.9K | — | 80.5K | — | 8.9K | 471.3K | 17.08% | ↗ |
| 193 | 2003 | Carol R. Kaufman Vice President of Legal Affairs, Secretary and Chief Administrative Officer | 225.0K | 156.9K | — | 80.5K | — | 1.7K | 464.1K | 17.34% | ↗ |
| 194 | 2003 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 234.9K | 109.0K | — | 20.0K | — | 41.8K | 405.7K | 4.93% | ↗ |
| 195 | 2003 | Nicholas J. Pichotta President and Chief Executive Officer of CooperSurgical, Inc. | 234.9K | 109.0K | — | 20.0K | — | 2.2K | 366.1K | 5.46% | ↗ |
| 196 | 2002 | A. Thomas Bender President & Chief Executive Officer | 436.5K | 325.2K | — | 166.0K | — | 10.3K | 937.9K | 17.70% | ↗ |
| 197 | 2002 | A. Thomas Bender President and Chief Executive Officer | 436.5K | 325.2K | — | 166.0K | — | 3.1K | 930.7K | 17.84% | ↗ |
| 198 | 2002 | Robert S. Weiss Executive Vice President & Chief Operating Officer | 307.2K | 206.0K | — | 54.0K | — | 9.5K | 576.7K | 9.36% | ↗ |
| 199 | 2002 | Robert S. Weiss Executive Vice President and Chief Financial Officer | 307.2K | 206.0K | — | 54.0K | — | 2.3K | 569.5K | 9.48% | ↗ |
| 200 | 2002 | Gregory A. Fryling President & Chief Operating Officer of CooperVision, Inc. | 220.9K | 159.6K | — | 40.0K | — | 7.3K | 427.8K | 9.35% | ↗ |
| 201 | 2002 | Nicholas J. Pichotta Chief Executive Officer of CooperSurgical, Inc. | 225.3K | 136.8K | — | 20.0K | — | 41.5K | 423.6K | 4.72% | ↗ |
| 202 | 2002 | Gregory A. Fryling Chief Operating Officer of CooperVision, Inc. | 220.9K | 159.6K | — | 40.0K | — | 1.3K | 421.8K | 9.48% | ↗ |
| 203 | 2002 | Carol R. Kaufman Sr. Vice President of Legal Affairs, Secretary & Chief Administrative Officer | 212.9K | 126.9K | — | 36.0K | — | 8.7K | 384.4K | 9.36% | ↗ |
| 204 | 2002 | Nicholas J. Pichotta President and Chief Executive Officer of CooperSurgical, Inc. | 225.3K | 136.8K | — | 20.0K | — | 1.9K | 384.0K | 5.21% | ↗ |
| 205 | 2002 | Carol R. Kaufman Vice President of Legal Affairs, Secretary and Chief Administrative Officer | 212.9K | 126.9K | — | 36.0K | — | 1.5K | 377.2K | 9.54% | ↗ |
| 206 | 2001 | A. Thomas Bender President and Chief Executive Officer | 426.5K | 285.8K | — | 66.0K | — | 3.0K | 781.2K | 8.45% | ↗ |
| 207 | 2001 | Robert S. Weiss Executive Vice President and Chief Financial Officer | 300.2K | 181.0K | — | 54.0K | — | 2.3K | 537.5K | 10.05% | ↗ |
| 208 | 2001 | Nicholas J. Pichotta President and Chief Executive Officer of CooperSurgical, Inc. | 221.5K | 122.2K | — | 20.0K | — | 1.9K | 365.6K | 5.47% | ↗ |
| 209 | 2001 | Carol R. Kaufman Vice President of Legal Affairs, Secretary and Chief Administrative Officer | 208.0K | 111.5K | — | 36.0K | — | 1.4K | 356.9K | 10.09% | ↗ |
| 210 | 2001 | Gregory A. Fryling Chief Operating Officer of CooperVision, Inc. | 211.0K | 67.0K | — | 40.0K | — | 1.3K | 319.3K | 12.53% | ↗ |
| 211 | 2000 | A. Thomas Bender President and Chief Executive Officer | 404.3K | 270.8K | — | 70.0K | — | 2.8K | 747.9K | 9.36% | ↗ |
| 212 | 2000 | Robert S. Weiss Executive Vice President and Chief Financial Officer | 284.6K | 171.9K | — | 54.0K | — | 1.1K | 511.5K | 10.56% | ↗ |
| 213 | 2000 | Carol R. Kaufman Vice President of Legal Affairs, Secretary and Chief Administrative Officer | 196.4K | 105.2K | — | 36.0K | — | 1.0K | 338.6K | 10.63% | ↗ |
| 214 | 2000 | Gregory A. Fryling Chief Operating Officer of CooperVision, Inc. | 195.4K | 95.2K | — | 36.0K | — | 932.00 | 327.5K | 10.99% | ↗ |
| 215 | 2000 | Nicholas J. Pichotta President and Chief Executive Officer of CooperSurgical, Inc. | 215.0K | 68.8K | — | 20.0K | — | 1.2K | 305.0K | 6.56% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Albert G. White | President, Chief Executive Officer & Non-Independent Director | 3M | male |
| Daniel G. McBride | Executive VP, COO General Counsel & Secretary | 1M | male |
| Brian G. Andrews | Executive VP, CFO, Treasurer & Principal Accounting Officer | 1M | male |
| Holly R. Sheffield | President of CooperSurgical, Inc. | 1M | female |
| Gerard H. Warner | President of CooperVision, Inc. | 1M | male |
| Agostino Ricupati | Senior Vice President & Tax | 670.7K | male |
| Kim Duncan | Vice President of Investor Relations & Risk Management | — | male |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-12-10 | 2026-01-12 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-24 | 2025-11-14 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-21 | 2025-11-14 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-15 | 2025-11-14 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-10 | 2025-11-14 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-10-01 | 2025-11-14 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-09-29 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-09-05 | 2025-10-03 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-08-26 | 2025-09-12 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-08-26 | 2025-09-12 | Ro Khanna | CA17 | — | Sale | $1,000 - $15,000 | ↗ |
| 2025-08-04 | 2025-09-12 | Ro Khanna | CA17 | Spouse | Purchase | $1,000 - $15,000 | ↗ |
| 2025-07-25 | 2025-08-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-15 | 2025-06-10 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-11-15 | 2024-12-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-31 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-10 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-02 | 2023-11-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2022-11-03 | 2022-12-06 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2022-09-29 | 2022-10-07 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-09-06 | 2022-10-07 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
